WO2022237338A1 - Device for extracting plasmid dna in bacteria - Google Patents
Device for extracting plasmid dna in bacteria Download PDFInfo
- Publication number
- WO2022237338A1 WO2022237338A1 PCT/CN2022/082709 CN2022082709W WO2022237338A1 WO 2022237338 A1 WO2022237338 A1 WO 2022237338A1 CN 2022082709 W CN2022082709 W CN 2022082709W WO 2022237338 A1 WO2022237338 A1 WO 2022237338A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mixing
- pump
- plasmid dna
- bacteria
- filter
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 90
- 241000894006 Bacteria Species 0.000 title claims abstract description 48
- 238000002156 mixing Methods 0.000 claims abstract description 204
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 75
- 239000007788 liquid Substances 0.000 claims abstract description 68
- 238000005336 cracking Methods 0.000 claims abstract description 33
- 230000009089 cytolysis Effects 0.000 claims description 65
- 239000006166 lysate Substances 0.000 claims description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 11
- 239000012295 chemical reaction liquid Substances 0.000 claims description 8
- -1 polypropylene Polymers 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000004743 Polypropylene Substances 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 229920001155 polypropylene Polymers 0.000 claims description 7
- 239000005909 Kieselgur Substances 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 37
- 238000000034 method Methods 0.000 abstract description 34
- 230000008569 process Effects 0.000 abstract description 15
- 238000012545 processing Methods 0.000 abstract description 7
- 238000013461 design Methods 0.000 abstract description 5
- 238000004140 cleaning Methods 0.000 abstract description 3
- 230000000712 assembly Effects 0.000 abstract 1
- 238000000429 assembly Methods 0.000 abstract 1
- 238000003912 environmental pollution Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 79
- 239000006228 supernatant Substances 0.000 description 24
- 238000001914 filtration Methods 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000005119 centrifugation Methods 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 238000000605 extraction Methods 0.000 description 10
- 239000012535 impurity Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000001962 electrophoresis Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 239000011148 porous material Substances 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 239000013611 chromosomal DNA Substances 0.000 description 6
- 238000013341 scale-up Methods 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000010008 shearing Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000006037 cell lysis Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000011031 large-scale manufacturing process Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003513 alkali Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000010146 3D printing Methods 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000011118 depth filtration Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 231100000707 mutagenic chemical Toxicity 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 229940021995 DNA vaccine Drugs 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/02—Apparatus for enzymology or microbiology with agitation means; with heat exchange means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/12—Apparatus for enzymology or microbiology with sterilisation, filtration or dialysis means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/33—Disintegrators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Definitions
- the disclosure relates to the technical field of biomedicine, in particular to a device for extracting plasmid DNA from bacteria.
- the current large-scale plasmid production technology mainly includes the following steps: vector construction, bacterial fermentation, cell lysis, solid-liquid separation and clarification, and plasmid purification.
- the current plasmid production process can produce plasmids that meet pharmaceutical quality standards and meet clinical requirements, there are still some difficult bottlenecks in these processes. For example, it is difficult to scale the output (kilogram level), the copy number and stability of the carrier, the DNA denaturation during the lysis process, the removal of HCD residues, the difficulty of solid-liquid separation, and the residue of endotoxin.
- Plasmid DNA for biopharmaceuticals is mainly produced in Escherichia coli, and alkaline lysis is the most widely used method for preparing plasmid DNA.
- Cells are lysed under alkaline conditions, and chromosomal DNA undergoes irreversible denaturation at the same time, and plasmid DNA can be refolded when the pH returns to neutral to separate plasmids from chromosomal DNA.
- the first and most critical step in plasmid renaturation is cell lysis. How to completely lyse cells, completely co-precipitate chromosomal DNA, and remove most of the RNA has become the core issue of cell lysis.
- the main problems in the current industrial-scale plasmid extraction process are: 1.
- Chinese patent CN205710712U discloses a cracking device in plasmid extraction, including a frame, at least one accommodation chamber rotatably arranged on the frame, and the accommodation chamber has a cavity for placing at least one bottle filled with culture fluid.
- the driver is used to drive the storage compartment to rotate, and the controller to control the drive to drive the storage compartment to drive the bottle body to rotate at the required speed, direction and number of turns.
- the above-mentioned technical solution is a relatively traditional processing method, which belongs to laboratory production. Although the structure is relatively simple, the production speed is relatively slow and continuous operation cannot be performed.
- Chinese patent CN111733060A discloses a plasmid DNA alkali lysis equipment, including bacteria liquid pipeline;
- the circulation pipeline is provided with a pump and a valve; an alkali lysate pre-distribution pipeline; a cell lysis reactor; a neutralization reactor; an acid pipeline; and a collection device.
- the above-mentioned technical device realizes continuous cracking, and cooperates with the corresponding filtering device, which can effectively improve the production level.
- the reaction device of this technical solution still needs to be ventilated for foaming and mixing, the structure of the device is complex, and the pipelines are arranged in a staggered manner, which is not conducive to pipeline cleaning.
- Chinese patent CN111808716A discloses a plasmid extraction device, including a lysis container, a precipitation container, an eluent container, a collection container, and a chromatography column.
- the lysis container and the precipitation container are communicated through a first connecting pipe, and the precipitation container It communicates with the chromatographic column through the second connecting pipe, and the eluent container communicates with the chromatographic column through the third connecting pipe.
- the first connecting pipe, the second connecting pipe and the third connecting pipe are all A valve is provided, the collection container is arranged under the chromatographic column, and the chromatographic column is connected with a vibrating mechanism.
- the above-mentioned technical solution adopts a vibrating structure, and the processing process is discontinuous, so the processing efficiency needs to be further improved, and this method has the problem of high host DNA residue, which needs further improvement.
- the present disclosure provides a device for extracting plasmid DNA from bacteria, which can solve the above problems.
- the present disclosure provides a device for extracting plasmid DNA in bacteria, comprising: a first mixing component and a second mixing component;
- the first mixing component is connected to the second mixing component through the cracking helical tube; at least one liquid inlet is provided on the connecting pipeline between the cracking helical tube and the second mixing component;
- the resuspended bacteria solution flows into the first mixing component and mixes, it is lysed through the lysis spiral tube to obtain a lysate, and then passed into the second mixing component to neutralize with solution III to obtain a neutralization reaction solution, and the lysate is passed through The liquid inlet enters the second mixing component.
- the structure of the first mixing component and the second mixing component can be one of stirring type, emulsifying type and centrifugal type.
- the structure of the first mixing component is stirring or emulsifying or centrifugal; the second mixing component is of centrifugal structure; preferably, both the first mixing component and the second mixing component are Mixing pump or agitator; more preferably, the first mixing component and the second mixing component are respectively the first mixing pump and the second mixing pump, and the impellers of the first mixing pump and the second mixing pump are preferably half Closed impeller.
- the impellers of the first mixing pump and the second mixing pump may include a back cover; a plurality of guide posts are evenly distributed on the back cover, and the guide posts are at least along the impeller.
- the outer surface in the direction of rotation is arc-shaped; the guide column is preferably a combination of one or more of a cylinder, a circular truncated column or a fan-shaped column.
- the diameter of the guide column is 0.5mm-40mm, preferably 2mm-10mm; the guide column is preferably a cylinder, or the cross-sectional area of the guide column is the largest in the middle, and the middle The cross-sectional area gradually decreases to both ends. Multiple diversion columns are evenly distributed, and the diameter is within an appropriate range, which can reduce shear force, prevent host DNA from contaminating the product, and enable lysis and neutralization to be automated.
- the cross-sectional area of the guide post is the largest in the middle, and the cross-sectional area gradually decreases from the middle to both ends.
- the structure of the guide post may be spindle-shaped.
- the internal diameter of the cracking spiral tube is 0.5cm-15cm, preferably 0.5cm-9cm, and the diameter of the pump head of the first mixing pump and the second mixing pump can be 2cm-100cm, preferably 4cm -30cm; the ratio range of the pump cavity volume of the first mixing pump and the second mixing pump to the rated feed volume per minute of a single mixing pump can be 1:6-1:1, and the preferred ratio is 1:6- 1:3; or the volumes of the pump chambers of the first mixing pump and the second mixing pump are both the volume of the feed liquid flowing through the pump chamber for 10s-60s, preferably the volume of the feed liquid flowing through the pump chamber for 10s-20s.
- the length of the guide posts is related to the distribution position, the length of each guide post decreases from the center of the rear cover to the outer edge, and the vertices of each guide post are located on the same paraboloid superior.
- both the liquid inlets of the first mixing pump and the second mixing pump can be arranged coaxially with the liquid outlet; the liquid inlet is located at the center of the pump casing, and the liquid outlet is located at the pump casing. center of the seat. In this way, when the fluid enters the pump chamber, it needs to pass through the center of the rear cover plate to the edge, and then it can be discharged after going around to the rear, so that it can fully contact the guide column, achieve the purpose of uniform mixing, and improve the quality of neutralization reaction.
- the device further includes a filter assembly, the liquid outlet end of the second mixing assembly is connected to the liquid inlet end of the filter assembly, and the neutralization reaction liquid is filtered through the filter assembly.
- the resuspension liquid includes solution I and bacteria containing plasmid DNA, and the resuspension liquid is mixed and transported to the first mixing component by the first delivery pump, and transported to the first mixing component by the second delivery pump. After the solution II of the first mixing component is mixed, it is passed into the cracking spiral tube for cracking.
- the structure of the filter assembly is one or more combinations of screen type, depth filter type, and centrifugal filter type.
- the structure of the filter assembly is a screen mesh or depth filter structure; the filter pore size is 0.2 ⁇ m-800 ⁇ m, specifically 0.2 ⁇ m-200 ⁇ m; the filter material includes but is not limited to cellulose, diatomaceous earth, Activated charcoal, polypropylene fibers and silicone.
- the filter material includes, but is not limited to, one or more combinations of cellulose, diatomaceous earth, activated carbon, polypropylene fiber, silica gel, polyethersulfone, nylon, and polyvinylidene fluoride.
- the structure of the filter assembly is a centrifugal structure; the centrifugal force is 1000g-20000g, the centrifugation time is 2min-60min, and the temperature is 2°C-40°C.
- the present disclosure also provides a method for extracting plasmid DNA in bacteria through the above-mentioned device, which realizes lysis and neutralization in the production process of the plasmid in two series-connected mixing components, specifically comprising the following steps:
- Step S1 mixing
- Step S2 cracking
- Step S3 neutralization
- step S1 is completed in the first mixing assembly
- step S2 is completed in the pyrolysis spiral tube
- step S3 is completed in the second mixing assembly
- the first mixing assembly, the cracking spiral tube and the second mixing assembly are sequentially connected in series.
- step S2 lysis is performed for 2 min-10 min, preferably 5 min.
- the rotation speed of the first mixing component is 50rpm-1500rpm, preferably 200rpm-500rpm; the rotation speed of the second mixing component is 20rpm-1000rpm, preferably 150rpm-500rpm.
- the method for extracting plasmid DNA in bacteria specifically includes the following steps:
- Step S1 After resuspending the bacterial cells with solution I, the resuspended bacterial liquid is obtained, and then the resuspended bacterial liquid and solution II are introduced into the first mixing component for mixing to obtain a bacterial cell mixed liquid;
- Step S2 The bacterial cell mixture flows out from the first mixing component, enters the lysis spiral tube for lysis, and obtains a lysate after lysis;
- Step S3 After the lysate and solution III enter the second mixing component, a neutralization reaction is carried out (or the lysate and solution III are premixed first, and then passed into the second mixing component) to obtain a neutralization reaction solution;
- the neutralized reaction liquid after obtaining the neutralized reaction liquid, it further includes the steps of solid-liquid separation and purification.
- step S1 the volume-to-mass ratio of the resuspended bacteria liquid to the bacteria is 3-20:1 (L:kg), more preferably 7:1 (L:kg).
- step S1 the volume ratio of solution I to solution II is 1:0.5-1:3, more preferably 1:1.
- the alkali lysis time is controlled to 2min-10min to ensure the complete lysis of the bacteria and the lysis effect.
- the solution I includes Tris-HCl and EDTA-2Na, further preferably, the Tris-HCl concentration is 2mmol/L-100mmol/L, and the EDTA-2Na concentration is 0.1mmol/L-50mmol/L, Solution I had a pH range of 6.0-9.0.
- the solution II includes NaOH and SDS, further preferably, the concentration of NaOH is 0.02mol/L-5mol/L, and the concentration of SDS is 0.1%-10%.
- step S2 the lysis time is 2 min-10 min, more preferably 5 min.
- the solution III includes KAc and NH 4 Ac, further preferably, the concentration of KAc is 0.1 mol/L-6 mol/L, and the concentration of NH 4 Ac is 0.2 mol/L-10 mol/L.
- step S3 the volume ratio of the lysate to the solution III is 1:0.3-5, more preferably 1:1.
- the lysis and neutralization effects are controlled by the above conditions to ensure the precipitation of host DNA and the removal effect of host RNA.
- This disclosure discloses the alkaline lysis and neutralization link in the plasmid production process, pioneeringly adopts the form of mixing components in series, and combines the delivery pump to make the lysis and neutralization process in a closed environment, reducing the chance of polluting the environment. It is convenient for CIP and SIP, and realizes continuous processing, which improves production efficiency and facilitates the expansion of production scale. Compared with the current mainstream production system of Airmix, it is easier to scale up and does not need to be scaled up. Customized bubble mixers of different sizes shortened the time to explore the amplification conditions and improved work efficiency;
- the disclosed equipment is simple, easy to operate, and low in cost, does not require professional customization and expensive equipment, is easy to scale up in production, and has low production cost;
- the full mixing of the liquid can ensure the gentle mixing and neutralization of the neutralization liquid, avoiding the use of complex low-shear neutralization equipment, sufficient mixing and short mixing time during lysis, mild and uniform conditions during neutralization, and after lysis and neutralization,
- the host DNA and RNA residues are lower than the effect of the foaming mixer, and the product quality is good; at the same time, the size of the pump chamber is optimized, so that the time and shear force of lysis and neutralization are suitable for product production, and the proportion of supercoiled plasmid after lysis is higher , the host DNA and RNA residues are less; in addition, there is no need to use a complex multi-stage membrane filtration system, and there is no need for overnight precipitation after lysis.
- the equipment can be cleaned directly with CIP, which meets the production specifications of pharmaceutical production and saves Process time, reduce cost.
- the cracking neutralization time and shear force are suitable for product production, and at the same time, it is convenient to expand the production scale; the shape and size of the mixing pump head are optimized, Using 3D printing technology, the design and customization of the pump head can reduce the shear force under the premise of ensuring the mixing effect, prevent the host DNA from contaminating the product, and enable the lysis and neutralization to be automated.
- reagents can use general reagents or meet the pharmaceutical grade, do not use acid to neutralize, have low requirements on plant equipment, and are suitable for large-scale production.
- Fig. 1 is the schematic diagram of the device for extracting plasmid DNA in bacteria of the present disclosure
- Fig. 2 is a perspective view of the impeller of the first mixing assembly in Embodiment 1 of the present disclosure
- FIG. 3 is a perspective view of a second mixing component in Embodiment 1 of the present disclosure.
- Figure 4 is an exploded view of the second mixing assembly in Figure 3;
- Fig. 5 is a structural diagram of the second mixing assembly in Fig. 3 after the pump casing is removed;
- Fig. 6 is a perspective view of the impeller of the second mixing assembly in Fig. 3;
- Fig. 7 is a comparison chart of product electrophoresis results in Example 1 of the present disclosure, wherein, lane 1: Marker, lane 2: centrifuged supernatant, lane 3: control;
- Fig. 8 is a side view of the impeller of the second mixing assembly in Embodiment 2 of the present disclosure.
- Fig. 9 is a perspective view of a second mixing component in Embodiment 3 of the present disclosure.
- FIG. 10 is a perspective view of the second mixing component in Embodiment 3 of the present disclosure.
- Figure 11 is a comparison chart of the electrophoresis results of Examples 1, 4, and 5 of the present disclosure, wherein, lane 1: the supernatant of the neutralization reaction solution of Example 5, lane 2: the supernatant of the neutralization reaction solution of Example 1, and lane 3 : the neutralization reaction liquid supernatant of embodiment 4, swimming lane 4: standard substance, swimming lane 5: Marker;
- Fig. 12 is the electrophoresis result graph of comparative example 1 of the present disclosure, wherein, swimming lane 1: the neutralization reaction liquid supernatant of embodiment 1, swimming lane 2: the neutralization reaction liquid supernatant of comparative example 1, swimming lane 3: standard, swimming lane 4: Marker;
- FIG. 13 is a perspective view of the impeller of the second mixing assembly in Comparative Example 2 of the present disclosure
- Figure 15 is a comparison chart of the electrophoresis results of Example 1 and Comparative Example 3 of the present disclosure, wherein, lane 1: the supernatant of the neutralization reaction solution of Example 1, lane 2: the supernatant of the neutralization reaction solution of Comparative Example 3, and lane 3: Standard, lane 4: Marker;
- Fig. 16 is a perspective view of the diversion column in Embodiment 6 of the present disclosure; wherein, in Figs. 1-6, 9-10 and 16:
- 1-first mixing assembly 2-second mixing assembly; 202-pump base; 203-sealing ring; 204-impeller; 205-pump casing; 2021-annular groove; 3-lysis spiral tube; 4-filter assembly; 5-resuspended bacteria solution; 6-solution II; 7-solution III; 201-spindle.
- neutralization solution herein refers to "solution III”.
- the disclosed device for extracting plasmid DNA from bacteria includes: a first mixing component 1 , a second mixing component 2 and a filter component 4 .
- the two mixing components are distinguished by function, the first mixing component 1 can be a cracking mixing component, and the second mixing component 2 is a neutralizing mixing component.
- the first mixing component 1 and the second mixing component 2 are connected in series; a cracking spiral tube 3 is also connected in series between the two mixing components.
- the solution I required for the lysis reaction is mixed with bacteria containing plasmid DNA to form a resuspended bacteria solution 5, and the flow rate and flow rate are controlled by the first delivery pump, and then delivered to the first mixing component 1, that is, the lysis mixing pump.
- a first three-way joint that is, a "Y" connector
- the resuspended bacteria solution 5 and solution II 6 can be sent to the second delivery pump through the first delivery pump and the second delivery pump respectively.
- a three-way joint is passed into the first mixing component 1 for mixing to obtain a bacterial cell mixture.
- the liquid outlet end of the first mixing assembly 1 is connected to the liquid inlet end of the cracking spiral tube 3 ; the liquid outlet end of the cracking spiral tube 3 is connected to the liquid inlet end of the second mixing assembly 2 .
- a liquid inlet is provided on the pipeline between the cracking spiral tube 3 and the second mixing assembly 2, which is specifically the second three-way joint in the series connection pipeline, that is, a "Y"-shaped connector, and the second three-way joint One end is also connected to the container of solution III7 through the third delivery pump.
- the first mixing component 1 and the second mixing component 2 used in this embodiment can be agitators or mixing pumps, specifically the first mixing pumps and the second mixing pumps respectively, including but not limited to stirring pumps, emulsifying pumps , centrifugal pumps, etc., among which the stirring paddles of the stirring pump can be selected from paddle stirrer, pusher stirrer, turbine stirrer, anchor stirrer, frame stirrer, screw stirrer; the rotor and stator of the emulsification pump include But not limited to: coarse teeth, medium teeth, fine teeth.
- the first mixing assembly 1 is used for cracking reaction, preferably the first mixing assembly 1 structure is preferably one of agitation type or emulsification type or centrifugal type, specifically emulsification pump can be selected, and its blade structure can be as shown in Figure 2 ( Can also be the form of other emulsification pumps in the prior art, here only show it with Fig. 2);
- the second mixing assembly 2 is used for neutralization reaction, can choose centrifugal structure, as shown in Fig.
- the second mixing assembly 2 mainly includes a main shaft 201 , a pump base 202 , a sealing ring 203 , an impeller 204 , and a pump casing 205 .
- the fluid delivery route is shown by the arrow in Figure 3.
- the fluid enters the pump through the liquid inlet end at the center of the pump casing 205. After centrifugal mixing, it can flow out through the liquid outlet end of the pump casing 205.
- the inner tube of the liquid outlet The path is tangent to the pump lumen.
- One end of the main shaft 201 is connected to the output end of the external motor, and the other end passes through the center of the pump base 202 through the sealing device, and is fixedly connected with the impeller 204.
- the contact area between the pump base 202 and the pump casing 205 is processed with an annular groove for installing the seal. Circle 203.
- the impeller 204 is preferably a semi-closed impeller; however, the traditional impeller has a big disadvantage, that is, the shear force is relatively large, so in this embodiment, the impeller 204 is designed as shown in Figures 5 and 6, including a rear cover 2041 .
- a plurality of guide columns 2042 are evenly distributed on the rear cover 2041 , a total of 32 pieces, which surround the center in three layers, and the guide columns 2042 are perpendicular to the surface of the rear cover 2041 .
- the shape of the guide column 2042 can be one or more combinations of cylinder, circular truncated or fan-shaped truncated, preferably cylindrical.
- the diameter of the guide post 2042 is in the range of 0.5mm-40mm; after testing, a better effect can be obtained when the diameter is preferably in the range of 2mm-10mm.
- the second mixing component 2 can control the mixing effect and shear force of different scales by setting a certain speed range, combined with the first mixing component 1, it can realize the automatic cracking and neutralization of different scales of bacterial liquid, so as to realize continuous , large-scale production.
- the structure of the first mixing component 1 may also preferably be the same as that of the second mixing component 1 .
- the impeller speed of the second mixing assembly 2 is 20rpm-1000rpm, a better mixing effect is produced. It is also possible to change the pump head properties, size, and rotating speed for the second mixing assembly 2 to control the neutralization effect; the pump head diameter of the second mixing pump is 2cm-100cm, preferably 4cm-30cm, and the rotating speed is controlled at 20rpm-1000rpm, preferably 150rpm-500rpm, the ratio of the volume of the pump chamber to the rated feed volume per minute of the mixing pump is in the range of 1:6-1:1, preferably 1:6-1:3; or the volume of the pump chamber is designed so that the feed liquid flows through the pump The volume of 10s-60s in the cavity is preferably the volume of 10s-20s when the feed liquid flows through the pump cavity; it ensures complete neutralization and produces low shear force, reduces the breakage of chromosomal DNA, and improves the quality of plasmid DNA.
- the liquid outlet end of the second mixing assembly 2 is connected to the liquid inlet end of the filter assembly 4 .
- the structure of the filter assembly 4 is one or more combinations of screen type, depth filter type and centrifugal filter type.
- the structure of the filter assembly 4 in this embodiment is a deep filter structure; the filter pore size is 0.2 ⁇ m-800 ⁇ m; the optional filter pore size is between 0.1 ⁇ m-200 ⁇ m.
- Secondary clarification of the neutralized supernatant is carried out by means of deep filtration, and the filtered material components include but not limited to cellulose, diatomaceous earth, activated carbon, polypropylene fiber, silica gel and their combination products.
- the envelope area of the deep filter membrane is between 0.01m 2 -2m 2 .
- Step S1 Solution I and bacteria containing plasmid DNA are premixed to obtain a resuspended bacteria solution.
- the resuspended bacteria solution 5 and solution II 6 can be pumped to the first three-way joint through the first delivery pump for pre-preparation in the pipeline. Mixing, and then entering the first mixing component 1 for stirring and mixing to obtain a bacterial cell mixture;
- Step S2 Stir and mix the bacterial cell mixture into the lysis spiral tube 3 for lysis reaction, and then flow out to obtain the lysis solution;
- Step S3 After the lysate flowing out of the lysis spiral tube 3 is pre-mixed with solution III7, it is then transported to the second mixing component 2 through the second three-way joint (or the lysate flowing out of the lysis spiral tube 3 flows through the second delivery pump The solution III is delivered to the second three-way joint, and then passed into the second mixing component 2), a neutralization reaction occurs, and the neutralized reaction solution after neutralization is obtained;
- Step S4 After the neutralized neutralization reaction liquid flows out, it enters the filter assembly 4 for filtration, and performs solid-liquid separation and purification.
- step S1 the volume-to-mass ratio of the resuspended bacteria liquid to the bacteria is 3-20:1 (v:m), more preferably 7:1 (v:m).
- step S1 the volume ratio of solution I to solution II is 1:0.5-1:3, more preferably 1:1.
- solution I includes Tris-HCl and EDTA-2Na, further preferably, Tris-HCl concentration is 2mmol/L-100mmol/L, EDTA-2Na concentration is 0.1mmol/L-50mmol/L, the pH of solution I The range is 6.0-9.0.
- the solution II includes NaOH and SDS, further preferably, the concentration of NaOH is 0.02mol/L-5mol/L, and the concentration of SDS is 0.1%-10%.
- step S2 the lysis time is 2 min-10 min, more preferably 5 min.
- solution III includes KAc and NH 4 Ac, further preferably, the concentration of KAc is 0.1 mol/L-6 mol/L, and the concentration of NH 4 Ac is 0.2 mol/L-10 mol/L.
- step S3 the volume ratio of the lysate flowing out of the lysis spiral tube 3 to the solution III is 1:0.3-5, more preferably 1:1.
- the lysis and neutralization effects are controlled by the above conditions to ensure the precipitation of chromosomal DNA and the removal of host RNA.
- the solid-liquid separation method includes but is not limited to one or more combinations of filtration, depth filtration, centrifugation and other methods.
- the filtering material includes but not limited to one or more of cellulose, diatomaceous earth, activated carbon, polypropylene fiber and silica gel, and the filter pore size is between 0.2 ⁇ m and 800 ⁇ m; preferably, when deep filtration is selected , the depth filter material includes but not limited to one or more of cellulose, diatomaceous earth, activated carbon, polypropylene fiber and silica gel, the depth filter pore size is 0.1 ⁇ m-200 ⁇ m, and the depth filter membrane package area is 0.01m 2 -2m 2 ;
- the centrifugation method includes but is not limited to the selection of a desktop centrifuge, a tube centrifuge or a disc centrifuge, the centrifugal force is 1000g-20000g, the centrifugation time is 2min-60min
- the extraction device in the above-mentioned embodiments can be used in the following examples, if there is any difference, it will be shown specifically, and the specific method for extracting plasmid DNA from bacteria can be as follows:
- Embodiment 1 50L fermentation scale processing example
- the diameter of the pump head is 10 cm
- the impellers of the pump heads of the two pumps are shown in Figure 6
- the diameter of the diversion column is 5 mm.
- Escherichia coli (E.coli) containing plasmid A was fermented at a high density.
- the OD 600 measured by a spectrophotometer was 84.2, and 23.3 L of the fermentation broth was centrifuged to harvest 3684 g of bacterial cells with a wet weight of 15.8%.
- 3684g of cells were resuspended in a pH 8.0 resuspension (Solution I) composed of 25mM Tris-HCl and 10mM EDTA-2Na to obtain a resuspension liquid, the volume of which was 25.8L after resuspension (bacteria and resuspension The volume-to-volume ratio is 1:7).
- the bacterium mixed solution After being pumped out from the lysis mixing pump, the bacterium mixed solution enters the lysis spiral tube 3, which has an inner diameter of 1.9 cm and a length of 5 m.
- the lysis time in the lysis spiral tube 3 is 5 minutes to obtain a lysate.
- the lysate after lysis enters the neutralization mixing pump (second mixing component), and the other end of the neutralization mixing pump is composed of 1MKAc and 7M NH 4 Ac solution III (pre-cooled at 2-8°C) at 280ml/min
- the speed enters, and the speed of the neutralization mixing pump is set to 250rpm, wherein the diameter of the guide column on the neutralization mixing pump impeller is 5mm, the shape of the guide column is a cylinder, and the diameter of the pump head of the neutralization mixing pump is 8.5cm; wherein,
- the pump chamber volume of the neutralizing mixing pump is 1:4 in ratio to the rated feed volume per minute of the single mixing pump.
- the neutralization reaction solution is collected and entered into the filter assembly 4, and the centrifugal filtration method is selected, and the supernatant is collected by centrifugation for 20 minutes with a centrifugal force of 8000g for the next step of purification.
- the plasmid concentration measured in the resuspension solution was 545mg/L (measured by QIAGEN's plasmid mini-extraction kit), and the total amount of plasmid was 14.06g.
- the electrophoresis diagram is shown in Figure 7. From Figure 7, it can be seen that the purity of the plasmid in the supernatant lysed by the device and method of the present application is relatively high, and the RNA and host DNA are less.
- the plasmid DNA prepared by the above method was detected by HPLC test and pharmacopoeia method, and the results showed that the plasmid was the target plasmid, and the purity was high, the supercoiled ratio was greater than 95%, and the ring-opening ratio was less.
- the length of the guide column 2042 in this embodiment is related to the distribution position, the length of each guide column 2042 is gradually decreased from the center of the rear cover 2041 to the outer edge, and each guide column 2042
- the vertices of are all located on the same paraboloid, as shown by the dotted line in Figure 8.
- the inner surface of the pump housing 205 is also designed as a paraboloid, which is matched with the guide post 2042 .
- the structure of the filter assembly 4 is a centrifugal structure, which can be selected as a desktop, tube or disc centrifuge connected in series; the centrifugal force is 1000g-20000g, the centrifugation time is 2min-60min, and the temperature is 2°C-40°C.
- the liquid inlet and liquid outlet of the second mixing assembly 2 in this embodiment are arranged coaxially. As shown in Figures 9 and 10, the liquid inlet is arranged at the center of the pump casing 205, and The liquid outlet is not located on the peripheral side of the pump casing 205.
- the liquid outlet is set at the center of the pump base 202, that is, the rear cover At the rear of the plate 2041, an annular groove 2021 is processed around the rotating shaft, and the bottom of the groove or the side opening of the groove can be used as a liquid outlet, so that the fluid entering the pump chamber needs to pass through the center to the edge of the rear cover plate 2041, and then go around to the rear. It is discharged through the annular groove 2021, so that it can fully contact the guide column 2042, achieve the purpose of uniform mixing, and improve the quality of neutralization reaction.
- Example 1 The difference from Example 1 is that the rotation speed of the first mixing pump is 400 rpm, the rotation speed of the second mixing pump is 500 rpm, the diameter of the cracking spiral tube is 1.9 cm; the diameter of the pump head of the second mixing pump is 10 cm.
- the guide post is a cylinder with a diameter of 1mm. Everything else is the same.
- the bacterial suspension is 2.5L
- the rotating speed of the first mixing pump is 100rpm
- the rotating speed of the second mixing pump is 50rpm
- the diameter of the cracking spiral tube is 1.9cm
- the pump head of the second mixing pump The diameter is 10cm.
- the guide post is a cylinder with a diameter of 1mm. Everything else is the same.
- the diversion column 2042 in this embodiment is designed with a variable cross-section.
- the purpose is to further reduce the influence of shearing on the neutralization process.
- fluid motion analysis as shown by the arrow in Figure 16, a single During the rotation of the root guide column, the flow velocity distribution of the fluid relative to the main body; that is, it decreases from the middle layer to both sides. The reason is that the upper and lower sides of the fluid are respectively subjected to the viscous resistance of the pump casing, that is, the pump seat, and the velocity is distributed in a gradient.
- it is designed as a variable cross-section structure.
- the cross-section of a single guide column increases first and then decreases from the side of the pump casing to the side of the pump seat, forming a "spindle-shaped" structure, see Figure 16 for details.
- the relative velocity at the center of the diversion column 2042 is relatively high and the impact is strong, combined with the large radius of curvature and force-bearing area, it can effectively reduce the shearing effect on the plasmid and increase the yield of the plasmid to a certain extent.
- HCD residual host DNA
- E. coli residual DNA detection kit E. coli residual DNA detection kit.
- Table 1 the plasmid DNA was detected by HPLC test and Pharmacopoeia method, and the results showed that the plasmid was the target plasmid, and the purity was high, the supercoiled ratio was 95.92%, and the ring-opening ratio was less.
- Table 1 is sample plasmid and purity detection HPLC peak result table in embodiment 5
- Impurity 1 and Impurity 2 are unknown states of the plasmid.
- HCD residual host DNA
- Example 2 The difference from Example 1 is that in this example, after the lysis and neutralization, the solid-liquid separation is carried out by filter bag filtration and depth filtration.
- the purpose is to increase the processing capacity and increase the production efficiency in the enlarged production process, and at the same time reduce the mechanical shearing effect of the continuous centrifuge in production, reduce the generation of impurities and the destruction of the target plasmid.
- the impurity removal rate after primary filtration can reach 86.2%, the turbidity before and after filtration is 43NTU and 10.7NTU respectively, and the purity of the plasmid has not changed significantly after filtration.
- the filtrate is clearer and the turbidity can be reduced to below 3NTU, which can be directly purified downstream.
- the plasmid DNA was detected by HPLC, and the results showed that the plasmid was the target plasmid, and the purity was high.
- the supercoiled ratio reached 96.08%. After filtration with a 100 ⁇ m filter bag, the supercoiled ratio was 97.6%. After filtration with a 200 ⁇ m filter bag Finally, the supercoil ratio is 97.55%.
- Table 2 shows the results of HPLC detection of plasmid purity in the supernatant before and after filtration with 100 ⁇ m and 200 ⁇ m filter bags
- the neutralization step of Comparative Example 1 does not use a pump, but is carried out in a bubble mixer, and the specific steps are as follows:
- Escherichia coli containing plasmid A is fermented at a high density, and the OD600 measured by a spectrophotometer is 78.9. 23.5 L of the fermented liquid was taken and centrifuged to harvest 3603 g of bacterial cells with a wet weight of 15.3%.
- the cell resuspension of 3603g is in the pH 8.0 resuspension liquid (solution I) that is made of 25mM Tris-HCl and 10mM EDTA-2Na, obtains resuspension liquid, and volume is 25.2L (thalline and solution I mass volume The ratio is 1:7).
- the bacterial cell mixture After being pumped out from the lysis mixing pump, the bacterial cell mixture enters the lysis helical tube.
- the inner diameter of the lysis helical tube is 1.9 cm, the length is 5 m, and the lysis time in the lysis helical tube is 5 minutes to obtain the lysate.
- the lysed lysate enters another "Y"-shaped connector, and the solution III (pre-cooled at 2-8°C) composed of 1M KAc and 7M NH 4 Ac at the other end of the connector enters at a speed of 280ml/min. Enter the bubble mixer through the "Y" connector, and set the compressed air flow rate of the bubble mixer to 1.2L/min.
- the volume ratio of lysate and solution III is 1:1.
- the results showed that the plasmid concentration measured in the resuspended bacteria liquid was 570mg/L (calculated by extracting with the plasmid mini-extraction kit), and the total amount of the plasmid was 14.36g.
- Example 13 The difference from Example 1 is that the centrifugal pump head impeller used in the second mixing pump in Comparative Example 2 is shown in Figure 13, and the rest are the same.
- Example 1 The difference from Example 1 is that the impeller of the centrifugal pump head used in the second mixing pump in Comparative Example 3 is shown in FIG. 14 . The rest of the settings are the same.
- test electropherogram is shown in Figure 15. It can be seen from the figure that the content of host DNA and RNA in the lysed supernatant of the pump head in this comparative example is relatively high, which is not conducive to plasmid purification.
- the extraction device of the present disclosure fully mixes the final product when it is lysed and the mixing time is short, and the conditions are mild and uniform when neutralized. Effect, the product quality is better, and when the speed is moderate, the extracted plasmid DNA has less impurities and high yield.
- the two mixing components used can not only fully mix the bacterial solution and lysate, but also ensure the neutralization solution (solution III) is mixed and neutralized gently, avoiding the use of complex low-shear neutralization equipment, and fully mixed during lysis And the mixing time is short, the conditions are mild and uniform during neutralization, after lysis and neutralization, the host DNA and RNA residues are lower than the effect of the foaming mixer, and the product quality is good; at the same time, the size of the pump chamber is optimized, so that the lysis and neutralization The time and shearing force are suitable for product production, the proportion of supercoiled plasmid after lysis is high, and the host DNA and RNA are less residual; in addition, there is no need to use complex multi-stage membrane filtration systems, and no steps such as overnight precipitation after lysis , The equipment can be cleaned directly with CIP, which conforms to the production specifications of pharmaceutical production, and at the same time saves process time and reduces costs.
- solution III neutralization solution
- the cracking and neutralization time and shear force are suitable for product production, and at the same time facilitate the expansion of the production scale; optimize the shape and size of the mixing pump head , using 3D printing technology to design and customize the pump head. Under the premise of ensuring the mixing effect, the shear force is reduced, the host DNA is prevented from contaminating the product, and the lysis and neutralization can be automated.
- reagents can use general reagents or meet the pharmaceutical grade, do not use acid to neutralize, have low requirements on plant equipment, and are suitable for large-scale production.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The present application relates to the technical field of biomedicines, and discloses a device for extracting plasmid DNA in bacteria. The device comprises a first mixing assembly and a second mixing assembly; the first mixing assembly and the second mixing assembly are connected by means of a cracking spiral tube; and at least one liquid inlet is provided on a connecting pipeline between the cracking spiral tube and the second mixing assembly. The present application has the advantages that: by means of series connection between the mixing assemblies, the cracking and neutralization process is in a closed environment, thereby reducing the probability of environmental pollution, facilitating the cleaning after use, achieving continuous processing, and improving the production efficiency; and the device is simple, and is low in design and production cost.
Description
相关申请的交叉引用Cross References to Related Applications
本公开要求于2021年5月10日提交中国专利局的申请号为“CN 202110506985.5”名称为“用于提取细菌中质粒DNA的装置”的中国专利申请的优先权,其全部内容通过引用结合在本公开中。This disclosure claims the priority of the Chinese patent application with application number "CN 202110506985.5" entitled "Apparatus for Extracting Plasmid DNA from Bacteria" filed with the Chinese Patent Office on May 10, 2021, the entire contents of which are hereby incorporated by reference In this disclosure.
本公开涉及生物医药技术领域,尤其涉及一种用于提取细菌中质粒DNA的装置。The disclosure relates to the technical field of biomedicine, in particular to a device for extracting plasmid DNA from bacteria.
近年来,由于基因治疗和DNA疫苗的临床成功,对工业化规模的质粒发酵生产需求已经非常迫切。In recent years, due to the clinical success of gene therapy and DNA vaccines, the demand for industrial-scale plasmid fermentation production has become very urgent.
当前规模化质粒的生产技术主要包括以下几道工序:载体构建、细菌发酵、菌体裂解、固液分离及澄清、质粒纯化。虽然目前的质粒生产工艺可以生产出符合药学质量标准的质粒,能够满足临床要求,但在这些工艺中还存在一些难以克服的瓶颈。如产量规模化(千克级)较难,载体拷贝数、稳定性问题,裂解过程中导致DNA变性、HCD残留去除,固液分离较难,内毒素残留等难题。The current large-scale plasmid production technology mainly includes the following steps: vector construction, bacterial fermentation, cell lysis, solid-liquid separation and clarification, and plasmid purification. Although the current plasmid production process can produce plasmids that meet pharmaceutical quality standards and meet clinical requirements, there are still some difficult bottlenecks in these processes. For example, it is difficult to scale the output (kilogram level), the copy number and stability of the carrier, the DNA denaturation during the lysis process, the removal of HCD residues, the difficulty of solid-liquid separation, and the residue of endotoxin.
用于生物制药的质粒DNA主要在大肠杆菌中生产,碱裂解法是一种应用最为广泛的制备质粒DNA的方法。利用碱性条件将细胞裂解,同时染色体DNA发生不可逆变性,而质粒DNA在pH恢复中性时可复性的原理,将质粒与染色体DNA分离。质粒复性的第一步也是最关键的一步是细胞裂解,如何将细胞彻底裂解,染色体DNA完全共沉淀,去除大部分的RNA成为细胞裂解的核心问题。目前工业规模的质粒提取工艺存在的主要问题有:1、碱裂解无自动化设备或设备能力满足不了充分混合的要求;2、使用大量有机溶剂及酸液,这在大规模工业化生产中增加安全风险及对厂房设备要求较高;3、使用中和液(溶液Ⅲ)混合后,无自动化的混合设备或混合设备满足不了均匀且低剪切的混合要求;4、中和反应液固液分离生产成本较高;5、宿主DNA残留较高;6、RNA去除率较低,影响下游纯化。7、重复用管路设备清洗困难,不利于CIP清洗,而一次性耗材设备成本较高。Plasmid DNA for biopharmaceuticals is mainly produced in Escherichia coli, and alkaline lysis is the most widely used method for preparing plasmid DNA. Cells are lysed under alkaline conditions, and chromosomal DNA undergoes irreversible denaturation at the same time, and plasmid DNA can be refolded when the pH returns to neutral to separate plasmids from chromosomal DNA. The first and most critical step in plasmid renaturation is cell lysis. How to completely lyse cells, completely co-precipitate chromosomal DNA, and remove most of the RNA has become the core issue of cell lysis. The main problems in the current industrial-scale plasmid extraction process are: 1. There is no automation equipment for alkaline lysis or the equipment capacity cannot meet the requirements of sufficient mixing; 2. A large amount of organic solvents and acids are used, which increases safety risks in large-scale industrial production. And it has high requirements for plant equipment; 3. After mixing with neutralizing liquid (solution Ⅲ), there is no automatic mixing equipment or mixing equipment can not meet the mixing requirements of uniform and low shear; 4. Solid-liquid separation production of neutralization reaction liquid High cost; 5. High host DNA residue; 6. Low RNA removal rate, which affects downstream purification. 7. It is difficult to clean reusable pipeline equipment, which is not conducive to CIP cleaning, and the cost of disposable consumable equipment is relatively high.
中国专利CN205710712U公开了一种质粒提取中的裂解装置,包括机架,可转动地设置在机架上的至少一个容纳仓,容纳仓具有放置至少一个装有培养液的瓶体的腔体,用于驱动容纳仓转动的驱动件,以及控制驱动件驱动容纳仓带动瓶体以所需速度、方向和圈数转动的控制器。上述技术方案即为较为传统的加工手段,属于实验室生产,虽然结构较为简洁,但是生产速度较慢,不能进行连续作业。Chinese patent CN205710712U discloses a cracking device in plasmid extraction, including a frame, at least one accommodation chamber rotatably arranged on the frame, and the accommodation chamber has a cavity for placing at least one bottle filled with culture fluid. The driver is used to drive the storage compartment to rotate, and the controller to control the drive to drive the storage compartment to drive the bottle body to rotate at the required speed, direction and number of turns. The above-mentioned technical solution is a relatively traditional processing method, which belongs to laboratory production. Although the structure is relatively simple, the production speed is relatively slow and continuous operation cannot be performed.
中国专利CN111733060A公开了一种质粒DNA碱裂解设备,包括菌液管道;缓冲液管道;菌液悬浮循环装置,包括首尾相连构成回路的循环管道,连接所述的菌液管道和缓冲液管道;所述循环管道上设置有泵和阀门;碱裂解液预配管道;溶胞反应器;中和反应器;酸液管道;收集装置。上述技术装置实现了连续化的裂解,配合相应的过滤装置,可以有效提升生产水平。但是,该技术方案反应装置仍需要通气进行起泡混合,装置结构复杂,管路交错设置,并不利于管路清洗。Chinese patent CN111733060A discloses a plasmid DNA alkali lysis equipment, including bacteria liquid pipeline; The circulation pipeline is provided with a pump and a valve; an alkali lysate pre-distribution pipeline; a cell lysis reactor; a neutralization reactor; an acid pipeline; and a collection device. The above-mentioned technical device realizes continuous cracking, and cooperates with the corresponding filtering device, which can effectively improve the production level. However, the reaction device of this technical solution still needs to be ventilated for foaming and mixing, the structure of the device is complex, and the pipelines are arranged in a staggered manner, which is not conducive to pipeline cleaning.
中国专利CN111808716A公开了一种质粒提取装置,包括裂解容器、沉淀容器、洗脱液容器、收集容器和层析柱,所述裂解容器与沉淀容器之间通过第一连接管连通,所述沉淀容器与层析柱之间通过第二连接管连通,所述洗脱液容器与层析柱之间通过第三连接管连通,所述第一连接管、第二连接管和第三连接管上均设置有阀门,所述收集容器设置在层析柱的下方,所述层析柱连接有振动机构。上述技术方案采取了振动式结构,加工过程不连续,需要进一步提升加工效率,并且该种方式存在宿主DNA残留较高的问题,还需要进一步改进。Chinese patent CN111808716A discloses a plasmid extraction device, including a lysis container, a precipitation container, an eluent container, a collection container, and a chromatography column. The lysis container and the precipitation container are communicated through a first connecting pipe, and the precipitation container It communicates with the chromatographic column through the second connecting pipe, and the eluent container communicates with the chromatographic column through the third connecting pipe. The first connecting pipe, the second connecting pipe and the third connecting pipe are all A valve is provided, the collection container is arranged under the chromatographic column, and the chromatographic column is connected with a vibrating mechanism. The above-mentioned technical solution adopts a vibrating structure, and the processing process is discontinuous, so the processing efficiency needs to be further improved, and this method has the problem of high host DNA residue, which needs further improvement.
虽然我们为了解决目前大规模生产质粒DNA的方法存在的缺陷,先前研发了一种通过混合腔震荡的方式进行裂解、中和提取细菌中质粒DNA的方法(参见:200610114061.6,一种连续大量提取质粒的方法),但是其不容易放大,提取的质粒DNA的效率较低;为解决这一问题,我们又研发了一种通过气泡混合器提取质粒DNA的装置(参见:202011120617.9,用于提取细菌中质粒DNA的气泡发生装置),其使菌液与裂解液能均一且充分混合,气泡混合有效降低剪切力,有效提高收率与质量,但是此装置仍存在不容易放大的问题,需要根据规模定制不同大小的气泡混合器,摸索通气量,流速等放大条件。Although we have previously developed a method for lysing, neutralizing and extracting plasmid DNA in bacteria by mixing chamber vibrations in order to solve the defects in the current method for large-scale production of plasmid DNA (see: 200610114061.6, a continuous large-scale extraction of plasmid method), but it is not easy to amplify, and the efficiency of extracted plasmid DNA is low; in order to solve this problem, we have developed a device for extracting plasmid DNA through a bubble mixer (see: 202011120617.9, used to extract Plasmid DNA bubble generating device), which can make the bacteria liquid and lysate mix uniformly and fully, and the bubble mixing can effectively reduce the shear force and effectively improve the yield and quality. However, this device still has the problem that it is not easy to scale up. Customize bubble mixers of different sizes, and explore amplification conditions such as ventilation volume and flow rate.
因此,我们公开设计了一种新的质粒DNA的提取设备和方法,除了能有效控制混合过程的剪切力,更容易实现放大工艺,相比通过气泡混合器(气泡发生装置)的方式,能有效提高裂解及中和过程的混合效率,增加收率;通过易控地调节混合参数,能有效控制剪切力,提高质粒质量。并且该装置原理简单,可精准调控,因此缩短放大条件摸索的时间,进一步提高工作效率,会大大促进连续地、大规模提取质粒DNA相关研究的发展,具有重要意义。Therefore, we have publicly designed a new extraction equipment and method for plasmid DNA. In addition to effectively controlling the shear force in the mixing process, it is easier to realize the scale-up process. Compared with the method of using a bubble mixer (bubble generating device), it can Effectively improve the mixing efficiency of the cracking and neutralization process and increase the yield; by adjusting the mixing parameters in an easy-to-control way, the shear force can be effectively controlled and the quality of the plasmid can be improved. Moreover, the device is simple in principle and can be precisely regulated. Therefore, shortening the time for exploring amplification conditions and further improving work efficiency will greatly promote the development of continuous and large-scale extraction of plasmid DNA, which is of great significance.
发明内容Contents of the invention
有鉴于此,本公开提供一种用于提取细菌中质粒DNA的装置,能够解决上述问题。In view of this, the present disclosure provides a device for extracting plasmid DNA from bacteria, which can solve the above problems.
本公开提供一种用于提取细菌中质粒DNA的装置,包括:第一混合组件和第二混合组件;The present disclosure provides a device for extracting plasmid DNA in bacteria, comprising: a first mixing component and a second mixing component;
所述第一混合组件与所述第二混合组件通过所述裂解螺旋管相连接;所述裂解螺旋管与所述第二混合组件的连接管路上设有至少一个进液口;The first mixing component is connected to the second mixing component through the cracking helical tube; at least one liquid inlet is provided on the connecting pipeline between the cracking helical tube and the second mixing component;
重悬菌液流入所述第一混合组件混合后,通过所述裂解螺旋管裂解得到裂解液,再通入 所述第二混合组件与溶液Ⅲ中和得到中和反应液,所述裂解液通过所述进液口进入所述第二混合组件。After the resuspended bacteria solution flows into the first mixing component and mixes, it is lysed through the lysis spiral tube to obtain a lysate, and then passed into the second mixing component to neutralize with solution III to obtain a neutralization reaction solution, and the lysate is passed through The liquid inlet enters the second mixing component.
在一些实施方式中,所述第一混合组件和第二混合组件的结构均可为搅拌式、乳化式、离心式中的一种。In some embodiments, the structure of the first mixing component and the second mixing component can be one of stirring type, emulsifying type and centrifugal type.
在一些实施方式中,所述第一混合组件结构为搅拌式或乳化式或离心式;所述第二混合组件为离心式结构;优选地,所述第一混合组件和第二混合组件均为混合泵或搅拌器;更优选地,所述第一混合组件和第二混合组件分别为第一混合泵和第二混合泵,所述第一混合泵和第二混合泵的叶轮均优选为半闭式叶轮。通过采用混合泵的形式,使得裂解和中和过程在密闭的环境中,降低污染环境的几率,使用后方便进行CIP和SIP。In some embodiments, the structure of the first mixing component is stirring or emulsifying or centrifugal; the second mixing component is of centrifugal structure; preferably, both the first mixing component and the second mixing component are Mixing pump or agitator; more preferably, the first mixing component and the second mixing component are respectively the first mixing pump and the second mixing pump, and the impellers of the first mixing pump and the second mixing pump are preferably half Closed impeller. By adopting the form of a mixing pump, the cracking and neutralization process is carried out in a closed environment, reducing the chance of polluting the environment, and it is convenient to carry out CIP and SIP after use.
在一些实施方式中,所述第一混合泵和第二混合泵的叶轮均可包括后盖板;所述后盖板上均匀分布有多个导流柱,所述导流柱上至少沿叶轮旋转方向的外侧面呈弧面设置;所述导流柱优选为圆柱、圆台或扇形柱中的一种或多种的组合。In some embodiments, the impellers of the first mixing pump and the second mixing pump may include a back cover; a plurality of guide posts are evenly distributed on the back cover, and the guide posts are at least along the impeller. The outer surface in the direction of rotation is arc-shaped; the guide column is preferably a combination of one or more of a cylinder, a circular truncated column or a fan-shaped column.
在一些实施方式中,所述导流柱的直径为0.5mm-40mm,优选为2mm-10mm;所述导流柱优选为圆柱,或所述导流柱的截面积为中间最大,且由中间至两端的截面积逐渐变小。导流柱多个均匀分布,且直径在合适的范围内,能够减小剪切力,防止宿主DNA污染产品,使得裂解中和可以自动化进行。In some embodiments, the diameter of the guide column is 0.5mm-40mm, preferably 2mm-10mm; the guide column is preferably a cylinder, or the cross-sectional area of the guide column is the largest in the middle, and the middle The cross-sectional area gradually decreases to both ends. Multiple diversion columns are evenly distributed, and the diameter is within an appropriate range, which can reduce shear force, prevent host DNA from contaminating the product, and enable lysis and neutralization to be automated.
在一些实施方式中,所述导流柱的截面积中间最大,且由中间至两端的截面积逐渐变小,具体实施时,所述导流柱的结构可为纺锤形。In some embodiments, the cross-sectional area of the guide post is the largest in the middle, and the cross-sectional area gradually decreases from the middle to both ends. In specific implementation, the structure of the guide post may be spindle-shaped.
在一些实施方式中,所述裂解螺旋管内径为0.5cm-15cm,优选为0.5cm-9cm,所述第一混合泵和第二混合泵的泵头直径均可为2cm-100cm,优选为4cm-30cm;所述第一混合泵和第二混合泵的泵腔体积与单个混合泵额定每分钟进料体积的比值范围均可为1:6-1:1,优选的比例为1:6-1:3;或所述第一混合泵和第二混合泵的泵腔体积均为料液流经泵腔内10s-60s的体积,优选为料液流经泵腔内10s-20s的体积。In some embodiments, the internal diameter of the cracking spiral tube is 0.5cm-15cm, preferably 0.5cm-9cm, and the diameter of the pump head of the first mixing pump and the second mixing pump can be 2cm-100cm, preferably 4cm -30cm; the ratio range of the pump cavity volume of the first mixing pump and the second mixing pump to the rated feed volume per minute of a single mixing pump can be 1:6-1:1, and the preferred ratio is 1:6- 1:3; or the volumes of the pump chambers of the first mixing pump and the second mixing pump are both the volume of the feed liquid flowing through the pump chamber for 10s-60s, preferably the volume of the feed liquid flowing through the pump chamber for 10s-20s.
在一些实施方式中,所述导流柱的长度与分布位置关联,各导流柱的长度由所述后盖板的中心处向外缘依次递减,且各导流柱的顶点均位于同一抛物面上。In some embodiments, the length of the guide posts is related to the distribution position, the length of each guide post decreases from the center of the rear cover to the outer edge, and the vertices of each guide post are located on the same paraboloid superior.
在一些实施方式中,所述第一混合泵和第二混合泵的进液端均可与出液端同轴设置;所述进液端位于泵壳的中心处,所述出液端位于泵座的中心处。这样流体进入泵腔内需沿后盖板中心至边缘的顺序经过,绕至后方才可排出,使其充分接触导流柱,达到均匀混合的目的,提升中和反应质量。In some embodiments, both the liquid inlets of the first mixing pump and the second mixing pump can be arranged coaxially with the liquid outlet; the liquid inlet is located at the center of the pump casing, and the liquid outlet is located at the pump casing. center of the seat. In this way, when the fluid enters the pump chamber, it needs to pass through the center of the rear cover plate to the edge, and then it can be discharged after going around to the rear, so that it can fully contact the guide column, achieve the purpose of uniform mixing, and improve the quality of neutralization reaction.
在一些实施方式中,所述装置还包括过滤组件,所述第二混合组件的出液端连接至所述过滤组件的进液端,所述中和反应液通过所述过滤组件过滤。In some embodiments, the device further includes a filter assembly, the liquid outlet end of the second mixing assembly is connected to the liquid inlet end of the filter assembly, and the neutralization reaction liquid is filtered through the filter assembly.
在一些实施方式中,所述重悬菌液包括溶液Ⅰ和含有质粒DNA的菌体,所述重悬菌液通过第一输送泵混合输送至第一混合组件,与通过第二输送泵输送至第一混合组件的溶液Ⅱ混合后通入裂解螺旋管裂解。In some embodiments, the resuspension liquid includes solution I and bacteria containing plasmid DNA, and the resuspension liquid is mixed and transported to the first mixing component by the first delivery pump, and transported to the first mixing component by the second delivery pump. After the solution II of the first mixing component is mixed, it is passed into the cracking spiral tube for cracking.
在一些实施方式中,所述过滤组件结构为筛网式、深层过滤式、离心过滤式中的一种或多种组合。In some embodiments, the structure of the filter assembly is one or more combinations of screen type, depth filter type, and centrifugal filter type.
在一些实施方式中,所述过滤组件结构为筛网式或深层过滤式结构;过滤孔径为0.2μm-800μm,具体可选取0.2μm-200μm;过滤材质包括但不限于纤维素、硅藻土、活性炭、聚丙烯纤维和硅胶。In some embodiments, the structure of the filter assembly is a screen mesh or depth filter structure; the filter pore size is 0.2 μm-800 μm, specifically 0.2 μm-200 μm; the filter material includes but is not limited to cellulose, diatomaceous earth, Activated charcoal, polypropylene fibers and silicone.
在一些实施方式中,过滤材质包括但不限于纤维素、硅藻土、活性炭、聚丙烯纤维、硅胶、聚醚砜、尼龙、聚偏氟乙烯的一种或多种组合。In some embodiments, the filter material includes, but is not limited to, one or more combinations of cellulose, diatomaceous earth, activated carbon, polypropylene fiber, silica gel, polyethersulfone, nylon, and polyvinylidene fluoride.
在一些实施方式中,所述过滤组件结构为离心式结构;离心力为1000g-20000g,离心时间为2min-60min,温度为2℃-40℃。In some embodiments, the structure of the filter assembly is a centrifugal structure; the centrifugal force is 1000g-20000g, the centrifugation time is 2min-60min, and the temperature is 2°C-40°C.
本公开还提供一种通过上述装置用于提取细菌中质粒DNA的方法,在两个串联的混合组件中实现质粒生产过程中的裂解和中和,具体包括以下步骤:The present disclosure also provides a method for extracting plasmid DNA in bacteria through the above-mentioned device, which realizes lysis and neutralization in the production process of the plasmid in two series-connected mixing components, specifically comprising the following steps:
步骤S1:混合;Step S1: mixing;
步骤S2:裂解;Step S2: cracking;
步骤S3:中和;Step S3: neutralization;
其中,步骤S1在第一混合组件中完成,步骤S2在裂解螺旋管中完成,步骤S3在第二混合组件中完成,第一混合组件、裂解螺旋管和第二混合组件依次串联。Wherein, step S1 is completed in the first mixing assembly, step S2 is completed in the pyrolysis spiral tube, step S3 is completed in the second mixing assembly, and the first mixing assembly, the cracking spiral tube and the second mixing assembly are sequentially connected in series.
在一些实施方式中,在步骤S2中,裂解2min-10min,优选5min。In some embodiments, in step S2, lysis is performed for 2 min-10 min, preferably 5 min.
在一些实施方式中,所述第一混合组件的转速为50rpm-1500rpm,优选为200rpm-500rpm;所述第二混合组件的转速为20rpm-1000rpm,优选为150rpm-500rpm。In some embodiments, the rotation speed of the first mixing component is 50rpm-1500rpm, preferably 200rpm-500rpm; the rotation speed of the second mixing component is 20rpm-1000rpm, preferably 150rpm-500rpm.
在一些实施方式中,所述用于提取细菌中质粒DNA的方法具体包括以下步骤:In some embodiments, the method for extracting plasmid DNA in bacteria specifically includes the following steps:
步骤S1:用溶液I重悬菌体后,得到重悬菌液,再将重悬菌液、溶液II导入第一混合组件混合,得到菌体混合液;Step S1: After resuspending the bacterial cells with solution I, the resuspended bacterial liquid is obtained, and then the resuspended bacterial liquid and solution II are introduced into the first mixing component for mixing to obtain a bacterial cell mixed liquid;
步骤S2:所述菌体混合液从第一混合组件中流出,进入裂解螺旋管进行裂解,裂解后得到裂解液;Step S2: The bacterial cell mixture flows out from the first mixing component, enters the lysis spiral tube for lysis, and obtains a lysate after lysis;
步骤S3:所述裂解液与溶液III进入第二混合组件后,进行中和反应(或裂解液与溶液III先预混后,再通入第二混合组件),得到中和反应液;Step S3: After the lysate and solution III enter the second mixing component, a neutralization reaction is carried out (or the lysate and solution III are premixed first, and then passed into the second mixing component) to obtain a neutralization reaction solution;
在典型的实施方式中,得到中和反应液后,还包括将其进行固液分离和纯化的步骤。In a typical embodiment, after obtaining the neutralized reaction liquid, it further includes the steps of solid-liquid separation and purification.
其中,in,
步骤S1中,重悬菌液与菌体的体积质量比为3-20:1(L:kg),进一步优选为7:1(L:kg)。In step S1, the volume-to-mass ratio of the resuspended bacteria liquid to the bacteria is 3-20:1 (L:kg), more preferably 7:1 (L:kg).
步骤S1中,溶液I与溶液II的体积比为1:0.5-1:3,进一步优选为1:1。通过不同的管路粗细和长度,控制碱裂解时间为2min-10min,保证菌体裂解完全及裂解效果。In step S1, the volume ratio of solution I to solution II is 1:0.5-1:3, more preferably 1:1. Through different pipeline thickness and length, the alkali lysis time is controlled to 2min-10min to ensure the complete lysis of the bacteria and the lysis effect.
步骤S1中,所述溶液I包括Tris-HCl和EDTA-2Na,进一步优选地,所述Tris-HCl浓度为2mmol/L-100mmol/L,EDTA-2Na浓度为0.1mmol/L-50mmol/L,溶液I的pH范围为6.0-9.0。In step S1, the solution I includes Tris-HCl and EDTA-2Na, further preferably, the Tris-HCl concentration is 2mmol/L-100mmol/L, and the EDTA-2Na concentration is 0.1mmol/L-50mmol/L, Solution I had a pH range of 6.0-9.0.
步骤S1中,所述溶液II包括NaOH和SDS,进一步优选地,所述NaOH浓度为0.02mol/L-5mol/L,SDS浓度为0.1%-10%。In step S1, the solution II includes NaOH and SDS, further preferably, the concentration of NaOH is 0.02mol/L-5mol/L, and the concentration of SDS is 0.1%-10%.
步骤S2中,所述裂解的时间为2min-10min,进一步优选为5min。In step S2, the lysis time is 2 min-10 min, more preferably 5 min.
步骤S3中,所述溶液III包括KAc和NH
4Ac,进一步优选地,所述KAc浓度为0.1mol/L-6mol/L,NH
4Ac浓度为0.2mol/L-10mol/L。
In step S3, the solution III includes KAc and NH 4 Ac, further preferably, the concentration of KAc is 0.1 mol/L-6 mol/L, and the concentration of NH 4 Ac is 0.2 mol/L-10 mol/L.
步骤S3中,裂解液与溶液III的体积比为1:0.3-5,进一步优选为1:1。通过上述条件来控制裂解、中和效果,保证宿主DNA的沉淀和宿主RNA去除效果。In step S3, the volume ratio of the lysate to the solution III is 1:0.3-5, more preferably 1:1. The lysis and neutralization effects are controlled by the above conditions to ensure the precipitation of host DNA and the removal effect of host RNA.
本公开具有如下优点:The present disclosure has the following advantages:
本公开明在质粒生产过程中的碱裂解和中和环节,开拓性地采用混合组件串联的形式,并结合输送泵使得裂解和中和过程在密闭的环境中,降低污染环境的几率,使用后方便进行CIP和SIP,且实现了连续的加工,提升了生产效率,同时也方便生产规模的放大,相较于目前主流的气泡混合器Airmix的生产体系来讲,比较容易放大,不需要根据规模定制不同大小的气泡混合器,缩短了放大条件摸索的时间,提高了工作效率;This disclosure discloses the alkaline lysis and neutralization link in the plasmid production process, pioneeringly adopts the form of mixing components in series, and combines the delivery pump to make the lysis and neutralization process in a closed environment, reducing the chance of polluting the environment. It is convenient for CIP and SIP, and realizes continuous processing, which improves production efficiency and facilitates the expansion of production scale. Compared with the current mainstream production system of Airmix, it is easier to scale up and does not need to be scaled up. Customized bubble mixers of different sizes shortened the time to explore the amplification conditions and improved work efficiency;
进一步,本公开的设备简单,操作方便,且成本低廉,不需要专业的定制化、价格高昂的设备,易于在生产中放大,生产成本低;使用的两台混合组件既可以使菌液和裂解液的充分混合又可以保证和中和液温和地混合中和,避免使用复杂的低剪切中和设备,裂解时混合充分且混合时间较短,中和时条件温和均一,裂解中和后,宿主DNA和RNA残留均低于起泡混合器的效果,产品质量好;同时优化了泵腔的大小,使得裂解中和的时间和剪切力适合产品生产,裂解后的质粒超螺旋比例较高,宿主DNA、RNA残留较少;此外,不需要使用复杂的多级的膜过滤系统,裂解后也不需要过夜沉淀等步骤,设备可直接用CIP清洗,符合药物生产的生产规范,同时节省了工艺时间,降低成本。Furthermore, the disclosed equipment is simple, easy to operate, and low in cost, does not require professional customization and expensive equipment, is easy to scale up in production, and has low production cost; The full mixing of the liquid can ensure the gentle mixing and neutralization of the neutralization liquid, avoiding the use of complex low-shear neutralization equipment, sufficient mixing and short mixing time during lysis, mild and uniform conditions during neutralization, and after lysis and neutralization, The host DNA and RNA residues are lower than the effect of the foaming mixer, and the product quality is good; at the same time, the size of the pump chamber is optimized, so that the time and shear force of lysis and neutralization are suitable for product production, and the proportion of supercoiled plasmid after lysis is higher , the host DNA and RNA residues are less; in addition, there is no need to use a complex multi-stage membrane filtration system, and there is no need for overnight precipitation after lysis. The equipment can be cleaned directly with CIP, which meets the production specifications of pharmaceutical production and saves Process time, reduce cost.
进一步,通过优化泵腔的大小,结合调整泵腔和流速的比例,使得裂解中和的时间和剪切力适合产品生产,同时也方便生产规模的放大;对混合泵头的性状尺寸进行优化,使用3D打印技术,对泵头进行设计和定制在保证混合效果的前提下,降低了剪切力,防止宿主DNA污染产品,使得裂解中和可以自动化进行。Further, by optimizing the size of the pump chamber and adjusting the ratio of the pump chamber and flow rate, the cracking neutralization time and shear force are suitable for product production, and at the same time, it is convenient to expand the production scale; the shape and size of the mixing pump head are optimized, Using 3D printing technology, the design and customization of the pump head can reduce the shear force under the premise of ensuring the mixing effect, prevent the host DNA from contaminating the product, and enable the lysis and neutralization to be automated.
并且制备过程中不添加高风险的动物来源成分,如RNase、溶菌酶、蛋白酶K等,生产 工艺不使用有毒害的有机溶剂如异丙醇、酚、无水乙醇和其他诱变剂等,所用的试剂可以使用一般的试剂或满足药用级别,不使用酸液中和,对厂房设备要求较低,适合大规模生产。In addition, no high-risk animal-derived ingredients are added during the preparation process, such as RNase, lysozyme, proteinase K, etc., and the production process does not use toxic organic solvents such as isopropanol, phenol, absolute ethanol, and other mutagens. The reagents can use general reagents or meet the pharmaceutical grade, do not use acid to neutralize, have low requirements on plant equipment, and are suitable for large-scale production.
为了更清楚地说明本公开实施例,下面将对实施例中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅是本公开的一个或几个实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to illustrate the embodiments of the present disclosure more clearly, the accompanying drawings used in the embodiments will be briefly introduced below. Obviously, the accompanying drawings in the following description are only one or several embodiments of the present disclosure. Those of ordinary skill in the art can also obtain other drawings based on these drawings without any creative effort.
图1为本公开的用于提取细菌中质粒DNA的装置的示意图;Fig. 1 is the schematic diagram of the device for extracting plasmid DNA in bacteria of the present disclosure;
图2为本公开实施例1中第一混合组件叶轮立体图;Fig. 2 is a perspective view of the impeller of the first mixing assembly in Embodiment 1 of the present disclosure;
图3为本公开实施例1中第二混合组件立体图;FIG. 3 is a perspective view of a second mixing component in Embodiment 1 of the present disclosure;
图4为图3中的第二混合组件爆炸图;Figure 4 is an exploded view of the second mixing assembly in Figure 3;
图5为图3中第二混合组件去除泵壳后结构图;Fig. 5 is a structural diagram of the second mixing assembly in Fig. 3 after the pump casing is removed;
图6为图3中第二混合组件的叶轮立体图;Fig. 6 is a perspective view of the impeller of the second mixing assembly in Fig. 3;
图7为本公开实施例1中产品电泳结果对照图,其中,泳道1:Marker,泳道2:离心上清,泳道3:对照;Fig. 7 is a comparison chart of product electrophoresis results in Example 1 of the present disclosure, wherein, lane 1: Marker, lane 2: centrifuged supernatant, lane 3: control;
图8为本公开实施例2中第二混合组件叶轮侧视图;Fig. 8 is a side view of the impeller of the second mixing assembly in Embodiment 2 of the present disclosure;
图9为本公开实施例3中第二混合组件立体图;Fig. 9 is a perspective view of a second mixing component in Embodiment 3 of the present disclosure;
图10为本公开实施例3中第二混合组件立体图;10 is a perspective view of the second mixing component in Embodiment 3 of the present disclosure;
图11为本公开实施例1、4、5的电泳结果对照图,其中,泳道1:实施例5的中和反应液上清,泳道2:实施例1的中和反应液上清,泳道3:实施例4的中和反应液上清,泳道4:标准品,泳道5:Marker;Figure 11 is a comparison chart of the electrophoresis results of Examples 1, 4, and 5 of the present disclosure, wherein, lane 1: the supernatant of the neutralization reaction solution of Example 5, lane 2: the supernatant of the neutralization reaction solution of Example 1, and lane 3 : the neutralization reaction liquid supernatant of embodiment 4, swimming lane 4: standard substance, swimming lane 5: Marker;
图12为本公开对比例1的电泳结果图,其中,泳道1:实施例1的中和反应液上清,泳道2:对比例1的中和反应液上清,泳道3:标准品,泳道4:Marker;Fig. 12 is the electrophoresis result graph of comparative example 1 of the present disclosure, wherein, swimming lane 1: the neutralization reaction liquid supernatant of embodiment 1, swimming lane 2: the neutralization reaction liquid supernatant of comparative example 1, swimming lane 3: standard, swimming lane 4: Marker;
图13为本公开对比例2中第二混合组件叶轮立体图;13 is a perspective view of the impeller of the second mixing assembly in Comparative Example 2 of the present disclosure;
图14为本公开对比例3中第二混合组件叶轮立体图;14 is a perspective view of the impeller of the second mixing assembly in Comparative Example 3 of the present disclosure;
图15为本公开实施例1与对比例3电泳结果对照图,其中,泳道1:实施例1的中和反应液上清,泳道2:对比例3的中和反应液上清,泳道3:标准品,泳道4:Marker;Figure 15 is a comparison chart of the electrophoresis results of Example 1 and Comparative Example 3 of the present disclosure, wherein, lane 1: the supernatant of the neutralization reaction solution of Example 1, lane 2: the supernatant of the neutralization reaction solution of Comparative Example 3, and lane 3: Standard, lane 4: Marker;
图16为本公开实施例6中导流柱立体图;其中,图1-6、9-10和16中:Fig. 16 is a perspective view of the diversion column in Embodiment 6 of the present disclosure; wherein, in Figs. 1-6, 9-10 and 16:
1-第一混合组件;2-第二混合组件;202-泵座;203-密封圈;204-叶轮;205-泵壳;2021-环形槽;2041-后盖板;2042-导流柱;3-裂解螺旋管;4-过滤组件;5-重悬菌液;6-溶液Ⅱ;7-溶液Ⅲ;201-主轴。1-first mixing assembly; 2-second mixing assembly; 202-pump base; 203-sealing ring; 204-impeller; 205-pump casing; 2021-annular groove; 3-lysis spiral tube; 4-filter assembly; 5-resuspended bacteria solution; 6-solution II; 7-solution III; 201-spindle.
以下将结合实施例和附图对本公开的构思、具体结构及产生的技术效果进行清楚、完整的描述,以充分地理解本公开的目的、方案和效果。需要说明的是,在不冲突的情况下,本申请实施例中的特征可以相互组合。The concept, specific structure and technical effects of the present disclosure will be clearly and completely described below in conjunction with the embodiments and drawings, so as to fully understand the purpose, scheme and effect of the present disclosure. It should be noted that, in the case of no conflict, features in the embodiments of the present application may be combined with each other.
还需要说明的是,在本公开的描述中,除非另有明确的规定和限定,术语“设置”、“安装”、“相连”、“连接”等应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域技术人员而言,可以根据具体情况理解上述术语在本公开中的具体含义。It should also be noted that, in the description of the present disclosure, unless otherwise clearly stipulated and limited, the terms "setting", "installation", "connection", "connection" and the like should be interpreted in a broad sense, for example, it may be a fixed connection , can also be detachably connected, or integrally connected; can be mechanically connected, can also be electrically connected; can be directly connected, can also be indirectly connected through an intermediary, and can be internal communication between two components. Those skilled in the art can understand the specific meanings of the above terms in the present disclosure according to specific situations.
除非特别指明,本文中的“裂解溶液”均指“溶液Ⅱ”。Unless otherwise specified, "lysing solution" herein refers to "solution II".
除非特别指明,本文中的“中和液”均指“溶液Ⅲ”。Unless otherwise specified, "neutralization solution" herein refers to "solution III".
下面将结合附图,对本公开做进一步说明。The present disclosure will be further described below in conjunction with the accompanying drawings.
如图1所示,本公开的用于提取细菌中质粒DNA的装置,包括:第一混合组件1、第二混合组件2和过滤组件4。两混合组件按功能区分,第一混合组件1可为裂解混合组件,第二混合组件2为中和混合组件。As shown in FIG. 1 , the disclosed device for extracting plasmid DNA from bacteria includes: a first mixing component 1 , a second mixing component 2 and a filter component 4 . The two mixing components are distinguished by function, the first mixing component 1 can be a cracking mixing component, and the second mixing component 2 is a neutralizing mixing component.
第一混合组件1与第二混合组件2串联连接;两混合组件之间还串接有裂解螺旋管3。具体地,裂解反应所需的溶液Ⅰ与含质粒DNA的菌体配比后形成重悬菌液5,通过第一输送泵控制流量与流速,向第一混合组件1即裂解混合泵输送。具体实施时,输送管路上还串接有一个第一三通接头(即“Y”形连接器),重悬菌液5与溶液Ⅱ6可分别通过第一输送泵、第二输送泵送至第一三通接头处,再通入第一混合组件1混合,得到菌体混合液。The first mixing component 1 and the second mixing component 2 are connected in series; a cracking spiral tube 3 is also connected in series between the two mixing components. Specifically, the solution I required for the lysis reaction is mixed with bacteria containing plasmid DNA to form a resuspended bacteria solution 5, and the flow rate and flow rate are controlled by the first delivery pump, and then delivered to the first mixing component 1, that is, the lysis mixing pump. During specific implementation, a first three-way joint (that is, a "Y" connector) is connected in series on the delivery pipeline, and the resuspended bacteria solution 5 and solution II 6 can be sent to the second delivery pump through the first delivery pump and the second delivery pump respectively. A three-way joint is passed into the first mixing component 1 for mixing to obtain a bacterial cell mixture.
第一混合组件1的出液端连接裂解螺旋管3的进液端;裂解螺旋管3的出液端连接第二混合组件2的进液端。其中,裂解螺旋管3与第二混合组件2之间的管路上设有一个进液口,具体为串接管路中的第二三通接头,即“Y”形连接器,第二三通接头的一端还通过第三输送泵连接溶液Ⅲ7的容器。The liquid outlet end of the first mixing assembly 1 is connected to the liquid inlet end of the cracking spiral tube 3 ; the liquid outlet end of the cracking spiral tube 3 is connected to the liquid inlet end of the second mixing assembly 2 . Wherein, a liquid inlet is provided on the pipeline between the cracking spiral tube 3 and the second mixing assembly 2, which is specifically the second three-way joint in the series connection pipeline, that is, a "Y"-shaped connector, and the second three-way joint One end is also connected to the container of solution III7 through the third delivery pump.
优选地,本实施例所用的第一混合组件1和第二混合组件2可为搅拌器或混合泵,具体地可分别为第一混合泵和第二混合泵,包括不限于搅拌泵、乳化泵、离心泵等,其中搅拌泵的搅拌桨可选用桨式搅拌器、推进式搅拌器、涡轮式搅拌器、锚式搅拌器、框式搅拌器、螺旋式搅拌器;乳化泵的转子和定子包括但不限于:粗齿、中齿、细齿。通过一定规则形状的泵头,实现了溶液的充分混合,且剪切力较低,保证染色体DNA不发生大量断裂,且可以在密闭环境下进行,没有污染。进一步由于第一混合组件1用于裂解反应,优选第一混合组件1结构优选为搅拌式或乳化式或离心式其中一种,具体可选取乳化泵,其叶片结构可如图2中所示(还可为现有技术中的其他乳化泵的形式,此处仅以图2示之);第二混合组件2用 于中和反应,可选取离心式结构,如图3、4所示,第二混合组件2主要包括主轴201、泵座202、密封圈203、叶轮204、泵壳205。流体输送路线如图3中箭头所示方向,流体通过泵壳205中心处的进液端进入泵内部,经过离心混合后可通过泵壳205侧向设置的出液端流出,出液端内部管路与泵内腔相切。其中主轴201一端连接外部电机的输出端,另一端通过密封装置穿过泵座202的中心处,并与叶轮204固定连接,泵座202与泵壳205接触区域加工有环形槽,用于安装密封圈203。叶轮204优选为半闭式叶轮;但是传统的叶轮存在较大缺点,即剪切力比较大,故本实施例中,叶轮204如图5、6所示设计,包括后盖板2041。后盖板2041上均匀分布有多个导流柱2042,共计32根,分三层环绕中心处,且导流柱2042垂直于后盖板2041的表面。进一步,为了更好的降低产生的剪切力,导流柱2042的形状可为圆柱、圆台或扇形台的一种或多种组合,优选为圆柱。导流柱2042的直径范围为0.5mm-40mm;经检验,优选直径为2mm-10mm时可获得较佳的效果。通过优化设计可以减小剪切力,防止宿主DNA污染产品,使得裂解中和可以自动化进行。经过实验可知第二混合组件2通过设定一定转速范围,控制不同规模的混合效果及剪切力的大小,结合第一混合组件1可实现不同规模的菌液自动裂解、中和,从而实现连续化、大规模生产。Preferably, the first mixing component 1 and the second mixing component 2 used in this embodiment can be agitators or mixing pumps, specifically the first mixing pumps and the second mixing pumps respectively, including but not limited to stirring pumps, emulsifying pumps , centrifugal pumps, etc., among which the stirring paddles of the stirring pump can be selected from paddle stirrer, pusher stirrer, turbine stirrer, anchor stirrer, frame stirrer, screw stirrer; the rotor and stator of the emulsification pump include But not limited to: coarse teeth, medium teeth, fine teeth. Through a pump head with a certain regular shape, the solution is fully mixed, and the shear force is low, which ensures that the chromosomal DNA does not undergo a large number of breaks, and can be carried out in a closed environment without pollution. Further because the first mixing assembly 1 is used for cracking reaction, preferably the first mixing assembly 1 structure is preferably one of agitation type or emulsification type or centrifugal type, specifically emulsification pump can be selected, and its blade structure can be as shown in Figure 2 ( Can also be the form of other emulsification pumps in the prior art, here only show it with Fig. 2); The second mixing assembly 2 is used for neutralization reaction, can choose centrifugal structure, as shown in Fig. 3,4, the second The second mixing assembly 2 mainly includes a main shaft 201 , a pump base 202 , a sealing ring 203 , an impeller 204 , and a pump casing 205 . The fluid delivery route is shown by the arrow in Figure 3. The fluid enters the pump through the liquid inlet end at the center of the pump casing 205. After centrifugal mixing, it can flow out through the liquid outlet end of the pump casing 205. The inner tube of the liquid outlet The path is tangent to the pump lumen. One end of the main shaft 201 is connected to the output end of the external motor, and the other end passes through the center of the pump base 202 through the sealing device, and is fixedly connected with the impeller 204. The contact area between the pump base 202 and the pump casing 205 is processed with an annular groove for installing the seal. Circle 203. The impeller 204 is preferably a semi-closed impeller; however, the traditional impeller has a big disadvantage, that is, the shear force is relatively large, so in this embodiment, the impeller 204 is designed as shown in Figures 5 and 6, including a rear cover 2041 . A plurality of guide columns 2042 are evenly distributed on the rear cover 2041 , a total of 32 pieces, which surround the center in three layers, and the guide columns 2042 are perpendicular to the surface of the rear cover 2041 . Further, in order to better reduce the generated shearing force, the shape of the guide column 2042 can be one or more combinations of cylinder, circular truncated or fan-shaped truncated, preferably cylindrical. The diameter of the guide post 2042 is in the range of 0.5mm-40mm; after testing, a better effect can be obtained when the diameter is preferably in the range of 2mm-10mm. By optimizing the design, the shear force can be reduced, the host DNA can be prevented from contaminating the product, and the lysis and neutralization can be automated. Through experiments, it can be seen that the second mixing component 2 can control the mixing effect and shear force of different scales by setting a certain speed range, combined with the first mixing component 1, it can realize the automatic cracking and neutralization of different scales of bacterial liquid, so as to realize continuous , large-scale production.
在具体实施中,第一混合组件1的结构还可优选地与第二混合组件1的结构相同。In a specific implementation, the structure of the first mixing component 1 may also preferably be the same as that of the second mixing component 1 .
具体地,第二混合组件2的叶轮转速为20rpm-1000rpm时产生较好的混合效果。还可针对第二混合组件2改变泵头性状、大小、转速以控制中和效果;第二混合泵的泵头直径为2cm-100cm,优选为4cm-30cm,转速控制在20rpm-1000rpm,优选为150rpm-500rpm,泵腔体积与该混合泵额定每分钟进料体积的比值范围为1:6-1:1,优选为1:6-1:3;或泵腔体积设计为料液流经泵腔内10s-60s的体积,优选为料液流经泵腔内10s-20s的体积;保证中和完全且产生较低的剪切力,减少染色体DNA的断裂,提高质粒DNA的质量。Specifically, when the impeller speed of the second mixing assembly 2 is 20rpm-1000rpm, a better mixing effect is produced. It is also possible to change the pump head properties, size, and rotating speed for the second mixing assembly 2 to control the neutralization effect; the pump head diameter of the second mixing pump is 2cm-100cm, preferably 4cm-30cm, and the rotating speed is controlled at 20rpm-1000rpm, preferably 150rpm-500rpm, the ratio of the volume of the pump chamber to the rated feed volume per minute of the mixing pump is in the range of 1:6-1:1, preferably 1:6-1:3; or the volume of the pump chamber is designed so that the feed liquid flows through the pump The volume of 10s-60s in the cavity is preferably the volume of 10s-20s when the feed liquid flows through the pump cavity; it ensures complete neutralization and produces low shear force, reduces the breakage of chromosomal DNA, and improves the quality of plasmid DNA.
第二混合组件2的出液端连接过滤组件4的进液端。The liquid outlet end of the second mixing assembly 2 is connected to the liquid inlet end of the filter assembly 4 .
优选地,过滤组件4结构为筛网式、深层过滤式、离心过滤式中的一种或多种组合。具体地,本实施例中过滤组件4结构为深层过滤式结构;过滤孔径为0.2μm-800μm;具体可选过滤孔径在0.1μm-200μm之间。通过深层过滤的方式对中和后上清液进行二次澄清,过滤的材质成分包括不限于纤维素、硅藻土、活性炭、聚丙烯纤维、硅胶及其组合产品。深层过滤膜包膜面积在0.01m
2-2m
2之间。
Preferably, the structure of the filter assembly 4 is one or more combinations of screen type, depth filter type and centrifugal filter type. Specifically, the structure of the filter assembly 4 in this embodiment is a deep filter structure; the filter pore size is 0.2 μm-800 μm; the optional filter pore size is between 0.1 μm-200 μm. Secondary clarification of the neutralized supernatant is carried out by means of deep filtration, and the filtered material components include but not limited to cellulose, diatomaceous earth, activated carbon, polypropylene fiber, silica gel and their combination products. The envelope area of the deep filter membrane is between 0.01m 2 -2m 2 .
工作过程如下:The working process is as follows:
步骤S1:溶液Ⅰ、含质粒DNA的菌体预混得到重悬菌液,重悬菌液5与溶液Ⅱ6可分别通过第一输送泵送至第一三通接头处,进行管路内的预混合,之后进入第一混合组件1进行搅拌混匀,得到菌体混合液;Step S1: Solution Ⅰ and bacteria containing plasmid DNA are premixed to obtain a resuspended bacteria solution. The resuspended bacteria solution 5 and solution II 6 can be pumped to the first three-way joint through the first delivery pump for pre-preparation in the pipeline. Mixing, and then entering the first mixing component 1 for stirring and mixing to obtain a bacterial cell mixture;
步骤S2:搅拌混匀后的菌体混合液进入裂解螺旋管3进行裂解反应,之后流出,得到裂解液;Step S2: Stir and mix the bacterial cell mixture into the lysis spiral tube 3 for lysis reaction, and then flow out to obtain the lysis solution;
步骤S3:流出裂解螺旋管3的裂解液与溶液Ⅲ7预混后,再通过第二三通接头输送至第二混合组件2中(或流出裂解螺旋管3的裂解液,流过第二输送泵的溶液Ⅲ,均输送至第二三通接头处,再通入第二混合组件2中),发生中和反应,得到中和后的中和反应液;Step S3: After the lysate flowing out of the lysis spiral tube 3 is pre-mixed with solution III7, it is then transported to the second mixing component 2 through the second three-way joint (or the lysate flowing out of the lysis spiral tube 3 flows through the second delivery pump The solution III is delivered to the second three-way joint, and then passed into the second mixing component 2), a neutralization reaction occurs, and the neutralized reaction solution after neutralization is obtained;
步骤S4:中和后的中和反应液流出后进入过滤组件4过滤,进行固液分离和纯化。Step S4: After the neutralized neutralization reaction liquid flows out, it enters the filter assembly 4 for filtration, and performs solid-liquid separation and purification.
其中,in,
步骤S1中,重悬菌液与菌体的体积质量比为3-20:1(v:m),进一步优选为7:1(v:m)。In step S1, the volume-to-mass ratio of the resuspended bacteria liquid to the bacteria is 3-20:1 (v:m), more preferably 7:1 (v:m).
步骤S1中,溶液I与溶液II的体积比为1:0.5-1:3,进一步优选为1:1。In step S1, the volume ratio of solution I to solution II is 1:0.5-1:3, more preferably 1:1.
步骤S1中,溶液I包括Tris-HCl和EDTA-2Na,进一步优选地,Tris-HCl浓度为2mmol/L-100mmol/L,EDTA-2Na浓度为0.1mmol/L-50mmol/L,溶液I的pH范围为6.0-9.0。In step S1, solution I includes Tris-HCl and EDTA-2Na, further preferably, Tris-HCl concentration is 2mmol/L-100mmol/L, EDTA-2Na concentration is 0.1mmol/L-50mmol/L, the pH of solution I The range is 6.0-9.0.
步骤S1中,溶液II包括NaOH和SDS,进一步优选地,NaOH浓度为0.02mol/L-5mol/L,SDS浓度为0.1%-10%。In step S1, the solution II includes NaOH and SDS, further preferably, the concentration of NaOH is 0.02mol/L-5mol/L, and the concentration of SDS is 0.1%-10%.
步骤S2中,裂解的时间为2min-10min,进一步优选为5min。In step S2, the lysis time is 2 min-10 min, more preferably 5 min.
步骤S3中,溶液III包括KAc和NH
4Ac,进一步优选地,KAc浓度为0.1mol/L-6mol/L,NH
4Ac浓度为0.2mol/L-10mol/L。
In step S3, solution III includes KAc and NH 4 Ac, further preferably, the concentration of KAc is 0.1 mol/L-6 mol/L, and the concentration of NH 4 Ac is 0.2 mol/L-10 mol/L.
步骤S3中,流出裂解螺旋管3的裂解液与溶液III的体积比为1:0.3-5,进一步优选为1:1。通过上述条件来控制裂解、中和效果,保证染色体DNA的沉淀和宿主RNA去除效果。In step S3, the volume ratio of the lysate flowing out of the lysis spiral tube 3 to the solution III is 1:0.3-5, more preferably 1:1. The lysis and neutralization effects are controlled by the above conditions to ensure the precipitation of chromosomal DNA and the removal of host RNA.
步骤S4中,固液分离方式包括但不限于过滤、深层过滤、离心等方式中的一种或多种组合。优选地,选择过滤时,过滤的材质包括不限于纤维素、硅藻土、活性炭、聚丙烯纤维和硅胶中的一种或多种,过滤孔径在0.2μm-800μm;优选地,选择深层过滤时,深层过滤的材质包括不限于纤维素、硅藻土、活性炭、聚丙烯纤维和硅胶中的一种或多种,深层过滤孔径在0.1μm-200μm,深层过滤膜包面积在0.01m
2-2m
2;优选地,选择离心时,离心方式包括不限于选用台式离心机、管式离心机或碟式离心机,离心力为1000g-20000g,离心时间为2min-60min,离心温度为2℃-40℃。
In step S4, the solid-liquid separation method includes but is not limited to one or more combinations of filtration, depth filtration, centrifugation and other methods. Preferably, when filtering is selected, the filtering material includes but not limited to one or more of cellulose, diatomaceous earth, activated carbon, polypropylene fiber and silica gel, and the filter pore size is between 0.2 μm and 800 μm; preferably, when deep filtration is selected , the depth filter material includes but not limited to one or more of cellulose, diatomaceous earth, activated carbon, polypropylene fiber and silica gel, the depth filter pore size is 0.1μm-200μm, and the depth filter membrane package area is 0.01m 2 -2m 2 ; Preferably, when selecting centrifugation, the centrifugation method includes but is not limited to the selection of a desktop centrifuge, a tube centrifuge or a disc centrifuge, the centrifugal force is 1000g-20000g, the centrifugation time is 2min-60min, and the centrifugation temperature is 2°C-40°C .
上述实施例中的提取装置均可用于以下实施例,如有不同具体会示出,具体从细菌中提取质粒DNA的方法可如下所示:The extraction device in the above-mentioned embodiments can be used in the following examples, if there is any difference, it will be shown specifically, and the specific method for extracting plasmid DNA from bacteria can be as follows:
实施例1:50L发酵规模处理实例Embodiment 1: 50L fermentation scale processing example
实施例1的用于提取细菌中质粒DNA的装置,泵头直径为10cm,两个泵的泵头叶轮均如附图6所示,导流柱直径为5mm。In the device for extracting plasmid DNA from bacteria in Example 1, the diameter of the pump head is 10 cm, the impellers of the pump heads of the two pumps are shown in Figure 6, and the diameter of the diversion column is 5 mm.
(1)将含有质粒A的大肠杆菌(E.coli)高密度发酵菌液,分光光度计测定OD
600为84.2, 将发酵液23.3L离心收获菌体3684g,湿重为15.8%。将3684g的细胞重悬于由25mM Tris-HCl和10mM EDTA-2Na组成的pH为8.0重悬液(溶液Ⅰ)中,得重悬菌液,重悬后体积为25.8L(菌体与重悬体积重量体积比为1:7)。
(1) Escherichia coli (E.coli) containing plasmid A was fermented at a high density. The OD 600 measured by a spectrophotometer was 84.2, and 23.3 L of the fermentation broth was centrifuged to harvest 3684 g of bacterial cells with a wet weight of 15.8%. 3684g of cells were resuspended in a pH 8.0 resuspension (Solution I) composed of 25mM Tris-HCl and 10mM EDTA-2Na to obtain a resuspension liquid, the volume of which was 25.8L after resuspension (bacteria and resuspension The volume-to-volume ratio is 1:7).
(2)将重悬菌液,以140ml/min的速度泵送至裂解混合泵,同时将由0.2M NaOH和1%SDS组成的裂解溶液(溶液Ⅱ)以140ml/min的速度泵送至裂解混合泵(第一混合组件)。调节裂解混合泵转速为200rpm,开始裂解混合,得到菌体混合液。其中,裂解混合泵的泵腔体积为与单个混合泵额定每分钟进料体积的比值1:3。(2) Pump the resuspended bacteria to the lysis mixing pump at a speed of 140ml/min, and at the same time pump the lysis solution (solution II) composed of 0.2M NaOH and 1% SDS to the lysis mixing pump at a speed of 140ml/min Pump (first mixing component). Adjust the rotational speed of the lysis mixing pump to 200rpm, start lysis and mixing, and obtain the bacterial cell mixture. Among them, the pump chamber volume of the cracking mixing pump is 1:3 in ratio to the rated feed volume per minute of a single mixing pump.
(3)菌体混合液从裂解混合泵中泵出后,进入裂解螺旋管3,裂解螺旋管3内径为1.9cm,长度为5m,在裂解螺旋管3中裂解时间为5min,得到裂解液。(3) After being pumped out from the lysis mixing pump, the bacterium mixed solution enters the lysis spiral tube 3, which has an inner diameter of 1.9 cm and a length of 5 m. The lysis time in the lysis spiral tube 3 is 5 minutes to obtain a lysate.
(4)裂解后的裂解液进入中和混合泵(第二混合组件),中和混合泵另一端由1MKAc和7M NH
4Ac组成的溶液Ⅲ(预冷2-8℃)以280ml/min的速度进入,中和混合泵设置转速250rpm,其中,中和混合泵叶轮上的导流柱的直径为5mm,导流柱的形状为圆柱,中和混合泵的泵头直径为8.5cm;其中,中和混合泵的泵腔体积为与单个混合泵额定每分钟进料体积的比值1:4。
(4) The lysate after lysis enters the neutralization mixing pump (second mixing component), and the other end of the neutralization mixing pump is composed of 1MKAc and 7M NH 4 Ac solution III (pre-cooled at 2-8°C) at 280ml/min The speed enters, and the speed of the neutralization mixing pump is set to 250rpm, wherein the diameter of the guide column on the neutralization mixing pump impeller is 5mm, the shape of the guide column is a cylinder, and the diameter of the pump head of the neutralization mixing pump is 8.5cm; wherein, The pump chamber volume of the neutralizing mixing pump is 1:4 in ratio to the rated feed volume per minute of the single mixing pump.
(5)中和完成后,收集中和中和反应液,进入过滤组件4,选取离心式过滤方式,以离心力8000g,离心20min收集上清液进行下一步纯化。(5) After the neutralization is completed, the neutralization reaction solution is collected and entered into the filter assembly 4, and the centrifugal filtration method is selected, and the supernatant is collected by centrifugation for 20 minutes with a centrifugal force of 8000g for the next step of purification.
结果检测:Result detection:
重悬菌液测得质粒浓度为545mg/L(通过QIAGEN的质粒小提试剂盒测得),质粒总量为14.06g。The plasmid concentration measured in the resuspension solution was 545mg/L (measured by QIAGEN's plasmid mini-extraction kit), and the total amount of plasmid was 14.06g.
中和后得到中和反应液100L,离心后得到上清82L,以HPLC定量法测得质粒浓度为121.8mg/L(HPLC机型:Waters 2695;色谱柱型号:TOSOH,Tskgel DNA-NPR 4.6mm*7.5cm2.5μm,下述实施例中的HPLC测定条件相同)。裂解收率71%。After neutralization, 100L of neutralization reaction solution was obtained, and 82L of supernatant was obtained after centrifugation, and the plasmid concentration recorded by HPLC quantitative method was 121.8mg/L (HPLC model: Waters 2695; chromatographic column model: TOSOH, Tskgel DNA-NPR 4.6mm *7.5cm2.5μm, the HPLC measurement conditions in the following examples are the same). The cracking yield was 71%.
电泳图见图7,从图7可以看出通过本申请的装置和方法裂解后的上清中质粒纯度较高,RNA及宿主DNA较少。The electrophoresis diagram is shown in Figure 7. From Figure 7, it can be seen that the purity of the plasmid in the supernatant lysed by the device and method of the present application is relatively high, and the RNA and host DNA are less.
通过HPLC试验以及药典方法检测上述方法制得的质粒DNA,结果表明质粒为目的质粒,且纯度较高,超螺旋比例大于95%,开环比例较少。The plasmid DNA prepared by the above method was detected by HPLC test and pharmacopoeia method, and the results showed that the plasmid was the target plasmid, and the purity was high, the supercoiled ratio was greater than 95%, and the ring-opening ratio was less.
实施例2Example 2
在实施例1的基础上,本实施例中导流柱2042的长度与分布位置关联,各导流柱2042的长度由后盖板2041的中心处向外缘依次递减,且各导流柱2042的顶点均位于同一抛物面上,如图8中虚线所示。相应的泵壳205的内表面也设计为抛物面型,与导流柱2042相配合。On the basis of Embodiment 1, the length of the guide column 2042 in this embodiment is related to the distribution position, the length of each guide column 2042 is gradually decreased from the center of the rear cover 2041 to the outer edge, and each guide column 2042 The vertices of are all located on the same paraboloid, as shown by the dotted line in Figure 8. Correspondingly, the inner surface of the pump housing 205 is also designed as a paraboloid, which is matched with the guide post 2042 .
过滤组件4结构为离心式结构,可选为串接的台式、管式或碟式离心机;离心力为 1000g-20000g,离心时间为2min-60min,温度为2℃-40℃。The structure of the filter assembly 4 is a centrifugal structure, which can be selected as a desktop, tube or disc centrifuge connected in series; the centrifugal force is 1000g-20000g, the centrifugation time is 2min-60min, and the temperature is 2°C-40°C.
实施例3Example 3
在实施例1的基础上,本实施例中第二混合组件2的进液端与出液端同轴设置,结合图9、10所示,进液端设置于泵壳205的中心处,而出液端不在设于泵壳205的周侧面,为了进一步增加混合效果,避免进出液口相邻较近导致混合不均匀的情况,将出液口设于泵座202的中心处,即后盖板2041的后方,围绕转轴加工环形槽2021,并可在槽底或槽的侧面开口作为出液端,这样流体进入泵腔内需沿后盖板2041中心至边缘的顺序经过,绕至后方才可通过环形槽2021排出,使其充分接触导流柱2042,达到均匀混合的目的,提升中和反应质量。On the basis of Embodiment 1, the liquid inlet and liquid outlet of the second mixing assembly 2 in this embodiment are arranged coaxially. As shown in Figures 9 and 10, the liquid inlet is arranged at the center of the pump casing 205, and The liquid outlet is not located on the peripheral side of the pump casing 205. In order to further increase the mixing effect and avoid the situation where the liquid inlet and outlet are adjacent to each other and cause uneven mixing, the liquid outlet is set at the center of the pump base 202, that is, the rear cover At the rear of the plate 2041, an annular groove 2021 is processed around the rotating shaft, and the bottom of the groove or the side opening of the groove can be used as a liquid outlet, so that the fluid entering the pump chamber needs to pass through the center to the edge of the rear cover plate 2041, and then go around to the rear. It is discharged through the annular groove 2021, so that it can fully contact the guide column 2042, achieve the purpose of uniform mixing, and improve the quality of neutralization reaction.
实施例4Example 4
与实施例1不同的是,第一混合泵的转速为400rpm,第二混合泵的转速为500rpm,裂解螺旋管的直径为1.9cm;第二混合泵的泵头直径为10cm。导流柱为圆柱,其直径为1mm。其余皆相同。The difference from Example 1 is that the rotation speed of the first mixing pump is 400 rpm, the rotation speed of the second mixing pump is 500 rpm, the diameter of the cracking spiral tube is 1.9 cm; the diameter of the pump head of the second mixing pump is 10 cm. The guide post is a cylinder with a diameter of 1mm. Everything else is the same.
然后将其中和后的中和反应液进行琼脂糖核酸电泳,测试结果如图11中所示,发现实施例4中裂解上清中宿主DNA和RNA均高于实施例1裂解上清,证明转速偏高时,杂质会较多。Then the neutralized reaction solution after neutralization is carried out to agarose nucleic acid electrophoresis, the test results are as shown in Figure 11, and it is found that the host DNA and RNA in the lysed supernatant in Example 4 are higher than the lysed supernatant in Example 1, proving that the rotation speed When it is high, there will be more impurities.
实施例5Example 5
与实施例1不同的是,菌体重悬液为2.5L,第一混合泵的转速为100rpm,第二混合泵的转速为50rpm,裂解螺旋管的直径为1.9cm;第二混合泵的泵头直径为10cm。导流柱为圆柱,其直径为1mm。其余皆相同。Different from Example 1, the bacterial suspension is 2.5L, the rotating speed of the first mixing pump is 100rpm, the rotating speed of the second mixing pump is 50rpm, and the diameter of the cracking spiral tube is 1.9cm; the pump head of the second mixing pump The diameter is 10cm. The guide post is a cylinder with a diameter of 1mm. Everything else is the same.
然后将中和后得到中和反应液10L,离心得到上清液共7.8L,测得上清液质粒浓度为96mg/L(HPLC测定),裂解收率55.0%,电泳测试结果如图11中所示,从图11可以看出第一混合泵和第二混合泵转速较低时会导致混合和中和不充分,质粒DNA收率较实施例1低。Then obtain neutralization reaction solution 10L after neutralization, centrifuge to obtain supernatant 7.8L altogether, record supernatant plasmid concentration and be 96mg/L (HPLC measures), cleavage yield 55.0%, electrophoresis test result is shown in Fig. 11 As shown, it can be seen from FIG. 11 that when the rotating speeds of the first mixing pump and the second mixing pump are low, the mixing and neutralization are insufficient, and the yield of plasmid DNA is lower than that of Example 1.
实施例6Example 6
与实施例1不同的是,本实施例中导流柱2042为变截面设计,目的是为了进一步降低剪切了对中和过程的影响,通过流体运动分析,如图16中箭头所示,单根导流柱转动中,流体相对主体的流速分布情况;即从中间层向两边减小,原因分析为流体上下两侧分别受到泵壳即泵座的粘滞阻力,速度呈梯度分布,由此为了保持单根导流柱对流体中遗传物质产生的剪切力较为一致,故将其设计为变截面结构。具体地,以实施例1中圆柱体为例,单根导流柱的截面从泵壳一侧至泵座一侧依次为先增加后减小,形成“纺锤形”结构,具体参阅图16。上述设计,虽然导流柱2042中心处相对速度较大,冲击较强,但是结合较大曲率半径及受力面积,可以有效减少对质粒的剪切作用,一定程度上提升了质粒产率。Different from Embodiment 1, the diversion column 2042 in this embodiment is designed with a variable cross-section. The purpose is to further reduce the influence of shearing on the neutralization process. Through fluid motion analysis, as shown by the arrow in Figure 16, a single During the rotation of the root guide column, the flow velocity distribution of the fluid relative to the main body; that is, it decreases from the middle layer to both sides. The reason is that the upper and lower sides of the fluid are respectively subjected to the viscous resistance of the pump casing, that is, the pump seat, and the velocity is distributed in a gradient. In order to maintain a relatively consistent shear force generated by a single diversion column on the genetic material in the fluid, it is designed as a variable cross-section structure. Specifically, taking the cylinder in Example 1 as an example, the cross-section of a single guide column increases first and then decreases from the side of the pump casing to the side of the pump seat, forming a "spindle-shaped" structure, see Figure 16 for details. In the above design, although the relative velocity at the center of the diversion column 2042 is relatively high and the impact is strong, combined with the large radius of curvature and force-bearing area, it can effectively reduce the shearing effect on the plasmid and increase the yield of the plasmid to a certain extent.
实施例7Example 7
同实施例1,检测宿主DNA残留(HCD)结果为5.87μg/mg(E.coli残留DNA检测试剂盒)。如表1所示,通过HPLC试验以及药典方法检测质粒DNA,结果表明质粒为目的质粒,且纯度较高,超螺旋比例为95.92%,开环比例较少。Same as in Example 1, the result of detecting residual host DNA (HCD) was 5.87 μg/mg (E. coli residual DNA detection kit). As shown in Table 1, the plasmid DNA was detected by HPLC test and Pharmacopoeia method, and the results showed that the plasmid was the target plasmid, and the purity was high, the supercoiled ratio was 95.92%, and the ring-opening ratio was less.
表1为实施例5中样品质粒及纯度检测HPLC峰结果表Table 1 is sample plasmid and purity detection HPLC peak result table in embodiment 5
|
样品名称 | 杂质1,%Impurities 1,% | 开环,%open loop, % | 超螺旋,%Supercoil, % |
线性,%linear, | 杂质2,%Impurity 2,% | ||
| 离心后After centrifugation | NDND | 1.151.15 | 95.9295.92 | NDND | 2.932.93 |
备注:“ND”表示未检出。杂质1和杂质2为质粒的未知状态。Note: "ND" means not detected. Impurity 1 and Impurity 2 are unknown states of the plasmid.
实施例8Example 8
同实施例4,检测宿主DNA残留(HCD)结果为18.7μg/mg(E.coli残留DNA检测试剂盒)。Same as in Example 4, the result of detecting residual host DNA (HCD) was 18.7 μg/mg (E. coli residual DNA detection kit).
实施例9Example 9
与实施例1不同的是,本实施例中裂解中和后,采用滤袋过滤和深层过滤的方式进行固液分离。目的是提高放大生产过程中的处理量和提高生产效率,同时减少生产上连续式离心机的机械剪切作用,减少杂质产生和目的质粒被破坏。采用过滤面积为0.5m
2,孔径大小分别为100μm和200μm聚丙烯材质的滤袋进行初级过滤,之后采用过滤孔径为0.2-2μm,材质为纤维素和无机助滤剂复合材质的深层过滤进行二级过滤。初级过滤后杂质去除率可达86.2%,过滤前后的浊度分别为43NTU和10.7NTU,且过滤后质粒纯度未发生明显改变。二级过滤后,滤液更加澄清,浊度可降低至3NTU以下,可直接进行下游纯化。如表2所示,通过HPLC检测质粒DNA,结果表明质粒为目的质粒,且纯度较高,过滤前,超螺旋比例达96.08%,100μm滤袋过滤后,超螺旋比例97.6%,200μm滤袋过滤后,超螺旋比例97.55%。
The difference from Example 1 is that in this example, after the lysis and neutralization, the solid-liquid separation is carried out by filter bag filtration and depth filtration. The purpose is to increase the processing capacity and increase the production efficiency in the enlarged production process, and at the same time reduce the mechanical shearing effect of the continuous centrifuge in production, reduce the generation of impurities and the destruction of the target plasmid. Use polypropylene filter bags with a filter area of 0.5m 2 and a pore size of 100μm and 200μm for primary filtration, and then use a filter bag with a filter pore size of 0.2-2μm and a composite material of cellulose and inorganic filter aid for secondary filtration. level filtering. The impurity removal rate after primary filtration can reach 86.2%, the turbidity before and after filtration is 43NTU and 10.7NTU respectively, and the purity of the plasmid has not changed significantly after filtration. After secondary filtration, the filtrate is clearer and the turbidity can be reduced to below 3NTU, which can be directly purified downstream. As shown in Table 2, the plasmid DNA was detected by HPLC, and the results showed that the plasmid was the target plasmid, and the purity was high. Before filtration, the supercoiled ratio reached 96.08%. After filtration with a 100 μm filter bag, the supercoiled ratio was 97.6%. After filtration with a 200 μm filter bag Finally, the supercoil ratio is 97.55%.
表2为100μm和200μm滤袋过滤前后清液中质粒纯度HPLC检测结果Table 2 shows the results of HPLC detection of plasmid purity in the supernatant before and after filtration with 100 μm and 200 μm filter bags
|
样品名称 | 杂质1,%Impurities 1,% | 开环,%open loop, % | 超螺旋,%Supercoil, % |
线性,%linear, | 杂质2,%Impurity 2,% | ||
| 过滤前Before filtering | 0.590.59 | 0.740.74 | 96.0896.08 | NDND | 2.592.59 | ||
| 100μm过滤后After 100μm filtration | NDND | 0.280.28 | 97.6097.60 | NDND | 2.122.12 | ||
| 200μm过滤后After 200μm filtration | NDND | 0.340.34 | 97.5597.55 | NDND | 2.112.11 |
备注:“ND”表示未检出。HPLC进样前对均会对样品进行离心,取上清液进样。Note: "ND" means not detected. The samples were centrifuged before HPLC injection, and the supernatant was taken for injection.
对比例1Comparative example 1
与实施例1不同的是,对比例1的中和步骤不使用泵,在气泡混合器中进行,具体步骤如下:Different from Example 1, the neutralization step of Comparative Example 1 does not use a pump, but is carried out in a bubble mixer, and the specific steps are as follows:
(1)将含有质粒A的大肠杆菌高密度发酵菌液,分光光度计测定OD600为78.9。取该发酵液23.5L离心,收获菌体3603g,湿重为15.3%。将3603g的细胞重悬于由25mM Tris-HCl 和10mM EDTA-2Na构成的pH为8.0重悬液(溶液I)中,得重悬菌液,体积为25.2L(菌体与溶液I的质量体积比为1:7)。(1) Escherichia coli containing plasmid A is fermented at a high density, and the OD600 measured by a spectrophotometer is 78.9. 23.5 L of the fermented liquid was taken and centrifuged to harvest 3603 g of bacterial cells with a wet weight of 15.3%. The cell resuspension of 3603g is in the pH 8.0 resuspension liquid (solution I) that is made of 25mM Tris-HCl and 10mM EDTA-2Na, obtains resuspension liquid, and volume is 25.2L (thalline and solution I mass volume The ratio is 1:7).
(2)将重悬菌液与以140ml/min的速度泵送至“Y”形连接器的一侧,同时将由0.2M NaOH和1%SDS构成的裂解溶液(溶液II)以140ml/min的速度泵送至“Y”形连接器的另一侧。将“Y”形连接器接入裂解混合泵(第一混合组件),调节转速为200rpm,开始裂解混合,得到菌体混合液。其中,溶液I与溶液II的体积比为1:1。(2) The resuspended bacteria liquid is pumped to one side of the "Y" shape connector at a speed of 140ml/min, and the lysis solution (solution II) composed of 0.2M NaOH and 1% SDS is pumped at a speed of 140ml/min Speed pumps to the other side of the "Y" connector. Connect the "Y" connector to the lysis mixing pump (the first mixing component), adjust the rotation speed to 200 rpm, and start lysis and mixing to obtain a bacterial cell mixture. Wherein, the volume ratio of solution I to solution II is 1:1.
(3)菌体混合液从裂解混合泵中泵出后,进入裂解螺旋管,裂解螺旋管内径为1.9cm,长度为5m,在裂解螺旋管中裂解时间为5min,得到裂解液。(3) After being pumped out from the lysis mixing pump, the bacterial cell mixture enters the lysis helical tube. The inner diameter of the lysis helical tube is 1.9 cm, the length is 5 m, and the lysis time in the lysis helical tube is 5 minutes to obtain the lysate.
(4)裂解后的裂解液进入另一“Y”形连接器,连接器另一端由1M KAc和7M NH
4Ac组成的溶液III(预冷2-8℃)以280ml/min的速度进入,通过“Y”形连接器进入气泡混合器,气泡混合器设置压缩空气流速为1.2L/min。裂解液和溶液III的体积比为1:1。
(4) The lysed lysate enters another "Y"-shaped connector, and the solution III (pre-cooled at 2-8°C) composed of 1M KAc and 7M NH 4 Ac at the other end of the connector enters at a speed of 280ml/min. Enter the bubble mixer through the "Y" connector, and set the compressed air flow rate of the bubble mixer to 1.2L/min. The volume ratio of lysate and solution III is 1:1.
(5)中和完成后,收集中和反应液,以8000g离心力离心20min,收集到对比上清液,可进行下一步纯化。(5) After the neutralization is completed, the neutralization reaction solution is collected, centrifuged at 8000 g for 20 min, and the comparison supernatant is collected for further purification.
通过酶标仪方法检测,结果表明,重悬菌液测得质粒浓度为570mg/L(质粒小提试剂盒提取计算得出),质粒总量为14.36g。Detected by the microplate reader method, the results showed that the plasmid concentration measured in the resuspended bacteria liquid was 570mg/L (calculated by extracting with the plasmid mini-extraction kit), and the total amount of the plasmid was 14.36g.
中和后得到中和反应液101L,离心得到上清液共79.3L,测得对比上清液质粒浓度为116.3mg/L(HPLC测定),裂解收率64.2%。电泳结果如图12所示,从图12可以看出本对比例中和过程使用气泡发生器的方法得到质粒DNA与实施例1的方法得到的质粒DNA相比,质粒浓度相当,但是其宿主RNA较多,说明本申请的制备方法更优,并且更容易放大,操作简单。After neutralization, 101 L of neutralization reaction solution was obtained, and a total of 79.3 L of supernatant was obtained by centrifugation. The comparison supernatant plasmid concentration was measured to be 116.3 mg/L (as determined by HPLC), and the cleavage yield was 64.2%. The results of electrophoresis are shown in Figure 12. It can be seen from Figure 12 that the plasmid DNA obtained by using the bubble generator method in the neutralization process of this comparative example is compared with the plasmid DNA obtained by the method in Example 1. The plasmid concentration is equivalent, but the host RNA More, indicating that the preparation method of the present application is better, and it is easier to scale up and easy to operate.
对比例2Comparative example 2
与实施例1不同的是,对比例2中第二混合泵所用离心泵头叶轮如图13所示,其余皆相同。The difference from Example 1 is that the centrifugal pump head impeller used in the second mixing pump in Comparative Example 2 is shown in Figure 13, and the rest are the same.
通过酶标仪检测中和后得到中和反应液80L,离心得到上清液共66L,测得上清液质粒浓度为106.6mg/L(HPLC测定),裂解收率64.5%。裂解收率低于实施例1。80L of neutralization reaction solution was obtained after neutralization by a microplate reader, and a total of 66L of supernatant was obtained by centrifugation. The plasmid concentration of the supernatant was measured to be 106.6mg/L (as determined by HPLC), and the cleavage yield was 64.5%. Cracking yield is lower than embodiment 1.
对比例3Comparative example 3
与实施例1不同的是,对比例3中第二混合泵所用离心泵头叶轮如图14所示。其余设置均相同。The difference from Example 1 is that the impeller of the centrifugal pump head used in the second mixing pump in Comparative Example 3 is shown in FIG. 14 . The rest of the settings are the same.
与实施例1结果相比,测试电泳图如图15所示,从图中可以看出,该对比例中泵头裂解上清中宿主DNA和RNA含量均较多,不利于质粒纯化。Compared with the results of Example 1, the test electropherogram is shown in Figure 15. It can be seen from the figure that the content of host DNA and RNA in the lysed supernatant of the pump head in this comparative example is relatively high, which is not conducive to plasmid purification.
基于上述实施例结果可知,本公开的提取装置,最终产品裂解时混合充分且混合时间较 短,中和时条件温和均一,裂解中和后,宿主DNA和RNA残留均低于起泡混合器的效果,产品质量较好,且速度适中时提取的质粒DNA杂质少,收率高。Based on the results of the above examples, it can be seen that the extraction device of the present disclosure fully mixes the final product when it is lysed and the mixing time is short, and the conditions are mild and uniform when neutralized. Effect, the product quality is better, and when the speed is moderate, the extracted plasmid DNA has less impurities and high yield.
本公开在质粒生产过程中的碱裂解和中和环节,开拓性地采用混合组件串联的形式,并结合输送泵使得裂解和中和过程在密闭的环境中,降低污染环境的几率,使用后方便进行CIP和SIP,且实现了连续的加工,提升了生产效率,同时也方便生产规模的放大,相较于目前主流的气泡混合器Airmix的生产体系来讲,比较容易放大,不需要根据规模定制不同大小的气泡混合器,缩短了放大条件摸索的时间,提高工作效率;设备简单,操作方便,且成本低廉,不需要专业的定制化、价格高昂的设备,易于在生产中放大,生产成本低;使用的两台混合组件既可以使菌液和裂解液的充分混合又可以保证和中和液(溶液Ⅲ)温和地混合中和,避免使用复杂的低剪切中和设备,裂解时混合充分且混合时间较短,中和时条件温和均一,裂解中和后,宿主DNA和RNA残留均低于起泡混合器的效果,产品质量好;同时优化了泵腔的大小,使得裂解中和的时间和剪切力适合产品生产,裂解后的质粒超螺旋比例较高,宿主DNA、RNA残留较少;此外,不需要使用复杂的多级的膜过滤系统,裂解后也不需要过夜沉淀等步骤,设备可直接用CIP清洗,符合药物生产的生产规范,同时节省了工艺时间,降低成本。In the alkaline lysis and neutralization link in the plasmid production process, this disclosure pioneered the use of a series of mixing components in the form of series, combined with a delivery pump to make the lysis and neutralization process in a closed environment, reducing the chance of polluting the environment, and convenient after use. Carry out CIP and SIP, and achieve continuous processing, improve production efficiency, and facilitate the expansion of production scale. Compared with the current mainstream bubble mixer Airmix production system, it is easier to scale up and does not need to be customized according to scale Bubble mixers of different sizes shorten the time to explore the amplification conditions and improve work efficiency; the equipment is simple, easy to operate, and low in cost. It does not require professional customization and expensive equipment. It is easy to enlarge in production and low in production costs. ; The two mixing components used can not only fully mix the bacterial solution and lysate, but also ensure the neutralization solution (solution Ⅲ) is mixed and neutralized gently, avoiding the use of complex low-shear neutralization equipment, and fully mixed during lysis And the mixing time is short, the conditions are mild and uniform during neutralization, after lysis and neutralization, the host DNA and RNA residues are lower than the effect of the foaming mixer, and the product quality is good; at the same time, the size of the pump chamber is optimized, so that the lysis and neutralization The time and shearing force are suitable for product production, the proportion of supercoiled plasmid after lysis is high, and the host DNA and RNA are less residual; in addition, there is no need to use complex multi-stage membrane filtration systems, and no steps such as overnight precipitation after lysis , The equipment can be cleaned directly with CIP, which conforms to the production specifications of pharmaceutical production, and at the same time saves process time and reduces costs.
进一步,通过优化混合泵腔的大小,结合调整泵腔和流速的比例,使得裂解中和的时间和剪切力适合产品生产,同时也方便生产规模的放大;对混合泵头的性状尺寸进行优化,使用3D打印技术,对泵头进行设计和定制在保证混合效果的前提下,降低了剪切力,防止宿主DNA污染产品,使得裂解中和可以自动化进行。Further, by optimizing the size of the mixing pump chamber and adjusting the ratio of the pump chamber and flow rate, the cracking and neutralization time and shear force are suitable for product production, and at the same time facilitate the expansion of the production scale; optimize the shape and size of the mixing pump head , using 3D printing technology to design and customize the pump head. Under the premise of ensuring the mixing effect, the shear force is reduced, the host DNA is prevented from contaminating the product, and the lysis and neutralization can be automated.
并且制备过程中不添加高风险的动物来源成分,如RNase、溶菌酶、蛋白酶K等,生产工艺不使用有毒害的有机溶剂如异丙醇、酚、无水乙醇和其他诱变剂等,所用的试剂可以使用一般的试剂或满足药用级别,不使用酸液中和,对厂房设备要求较低,适合大规模生产。In addition, no high-risk animal-derived ingredients are added during the preparation process, such as RNase, lysozyme, proteinase K, etc., and the production process does not use toxic organic solvents such as isopropanol, phenol, absolute ethanol, and other mutagens. The reagents can use general reagents or meet the pharmaceutical grade, do not use acid to neutralize, have low requirements on plant equipment, and are suitable for large-scale production.
以上具体实施方式仅用以说明本公开的技术方案而非限制,尽管参照实例对本公开进行了详细说明,本领域的普通技术人员应当理解,可以对公开的技术方案进行修改或者等同替换,而不脱离本公开技术方案的精神和范围,其均应涵盖在本公开的权利要求范围当中。The above specific embodiments are only used to illustrate the technical solutions of the present disclosure and not to limit them. Although the present disclosure has been described in detail with reference to examples, those skilled in the art should understand that the disclosed technical solutions can be modified or equivalently replaced without Any deviation from the spirit and scope of the technical solutions of the present disclosure shall be included in the scope of the claims of the present disclosure.
Claims (10)
- 用于提取细菌中质粒DNA的装置,其特征在于,包括第一混合组件和第二混合组件;所述第一混合组件与所述第二混合组件通过裂解螺旋管相连接;所述裂解螺旋管与所述第二混合组件的连接管路上设有至少一个进液口;重悬菌液流入所述第一混合组件混合后,通过所述裂解螺旋管裂解得到裂解液,再通入所述第二混合组件与溶液Ⅲ中和得到中和反应液,所述裂解液通过所述进液口进入所述第二混合组件。The device for extracting plasmid DNA in bacteria is characterized in that it includes a first mixing assembly and a second mixing assembly; the first mixing assembly is connected to the second mixing assembly through a cracking spiral tube; the cracking spiral tube At least one liquid inlet is provided on the connecting pipeline with the second mixing component; after the resuspended bacteria liquid flows into the first mixing component and mixes, it is lysed by the lysis spiral tube to obtain a lysate, and then passed into the second mixing component. The second mixing component is neutralized with solution III to obtain a neutralized reaction solution, and the lysate enters the second mixing component through the liquid inlet.
- 根据权利要求1所述的用于提取细菌中质粒DNA的装置,其特征在于,所述第一混合组件和第二混合组件的结构均为搅拌式、乳化式、离心式中的一种,优选地,所述第一混合组件和第二混合组件均为混合泵或搅拌器,所述第一混合组件和第二混合组件可分别优选为第一混合泵和第二混合泵。The device for extracting plasmid DNA in bacteria according to claim 1, wherein the structure of the first mixing assembly and the second mixing assembly is one of stirring, emulsifying, and centrifugal, preferably Preferably, the first mixing component and the second mixing component are both mixing pumps or agitators, and the first mixing component and the second mixing component may be preferably the first mixing pump and the second mixing pump respectively.
- 根据权利要求2所述的用于提取细菌中质粒DNA的装置,其特征在于,所述第一混合泵和第二混合泵的叶轮均包括后盖板;所述后盖板上均匀分布有多个导流柱;所述导流柱上至少沿叶轮旋转方向的外侧面呈弧面设置。The device for extracting plasmid DNA in bacteria according to claim 2, wherein the impellers of the first mixing pump and the second mixing pump all include a back cover; A guide column; the outer surface of the guide column at least along the rotation direction of the impeller is arranged on an arc surface.
- 根据权利要求3所述的用于提取细菌中质粒DNA的装置,其特征在于,所述导流柱为圆柱、圆台或扇形柱中一种或多种的组合。The device for extracting plasmid DNA in bacteria according to claim 3, wherein the diversion column is a combination of one or more of cylinders, circular truncated columns or fan-shaped columns.
- 根据权利要求3所述的用于提取细菌中质粒DNA的装置,其特征在于,所述导流柱的横截面宽度最大值为0.5mm-40mm,优选为2mm-10mm;所述导流柱优选为圆柱,或所述导流柱的截面积为中间最大,且导流柱的截面积由中间至两端逐渐变小。The device for extracting plasmid DNA in bacteria according to claim 3, wherein the maximum cross-sectional width of the guide column is 0.5mm-40mm, preferably 2mm-10mm; the guide column is preferably It is a cylinder, or the cross-sectional area of the guide post is the largest in the middle, and the cross-sectional area of the guide post gradually decreases from the middle to both ends.
- 根据权利要求3所述的用于提取细菌中质粒DNA的装置,其特征在于,所述裂解螺旋管内径为0.5cm-15cm,优选为0.5cm-9cm;所述第一混合泵和第二混合泵的泵头直径均为2cm-100cm,优选为4cm-30cm;所述第一混合泵和第二混合泵的泵腔体积与单个混合泵额定每分钟进料体积的比值范围均为1:6-1:1,优选的比例为1:6-1:3;或所述第一混合泵和第二混合泵的泵腔体积设计均为料液流经泵腔内10s-60s的体积,优选为料液流经泵腔内10s-20s的体积。The device for extracting plasmid DNA in bacteria according to claim 3, wherein the internal diameter of the cracking helical tube is 0.5cm-15cm, preferably 0.5cm-9cm; the first mixing pump and the second mixing The diameter of the pump head of the pump is 2cm-100cm, preferably 4cm-30cm; the ratio range of the pump cavity volume of the first mixing pump and the second mixing pump to the rated feed volume per minute of a single mixing pump is 1:6 -1:1, the preferred ratio is 1:6-1:3; or the pump chamber volumes of the first mixing pump and the second mixing pump are designed to be the volume of the feed liquid flowing through the pump chamber for 10s-60s, preferably It is the volume of the feed liquid flowing through the pump cavity for 10s-20s.
- 根据权利要求3中所述的用于提取细菌中质粒DNA的装置,其特征在于,所述第一混合泵和第二混合泵的进液端均与出液端同轴设置;所述进液端位于泵壳的中心处,所述出液端位于泵座的中心处。According to the device for extracting plasmid DNA in bacteria described in claim 3, it is characterized in that the liquid inlet ends of the first mixing pump and the second mixing pump are coaxially arranged with the liquid outlet; the liquid inlet The outlet end is located at the center of the pump casing, and the outlet end is located at the center of the pump base.
- 根据权利要求1至7中任一项所述的用于提取细菌中质粒DNA的装置,其特征在于,所述装置还包括过滤组件,所述第二混合组件的出液端连接至所述过滤组件的进液端,所述中和反应液通过所述过滤组件过滤。The device for extracting plasmid DNA in bacteria according to any one of claims 1 to 7, wherein the device also includes a filter assembly, and the liquid outlet of the second mixing assembly is connected to the filter The liquid inlet end of the component, the neutralization reaction liquid is filtered through the filter component.
- 根据权利要求8所述的用于提取细菌中质粒DNA的装置,其特征在于,所述重悬菌液包括溶液Ⅰ和含有质粒DNA的菌体,所述重悬菌液通过第一输送泵混合输送至第一混合 组件,与通过第二输送泵输送至第一混合组件的溶液Ⅱ混合后通入裂解螺旋管裂解。The device for extracting plasmid DNA in bacteria according to claim 8, wherein the resuspended bacteria liquid includes solution I and bacteria containing plasmid DNA, and the resuspended bacteria liquid is mixed by the first delivery pump It is sent to the first mixing component, mixed with the solution II delivered to the first mixing component by the second delivery pump, and then passed into the cracking spiral tube for cracking.
- 根据权利要求8所述的用于提取细菌中质粒DNA的装置,其特征在于,所述过滤组件结构为筛网式、深层过滤式、离心过滤式中的一种或多种组合;优选地,所述过滤组件结构为筛网式或深层过滤式结构;过滤孔径为0.2μm-800μm;过滤材质为纤维素、硅藻土、活性炭、聚丙烯纤维或硅胶。The device for extracting plasmid DNA in bacteria according to claim 8, wherein the filter assembly structure is one or more combinations of screen mesh, depth filter, centrifugal filter; preferably, The structure of the filter assembly is a screen mesh or deep filter structure; the filter aperture is 0.2 μm-800 μm; the filter material is cellulose, diatomaceous earth, activated carbon, polypropylene fiber or silica gel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110506985.5A CN115404154A (en) | 2021-05-10 | 2021-05-10 | Device for extracting plasmid DNA from bacteria |
| CN202110506985.5 | 2021-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022237338A1 true WO2022237338A1 (en) | 2022-11-17 |
Family
ID=84029337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2022/082709 WO2022237338A1 (en) | 2021-05-10 | 2022-03-24 | Device for extracting plasmid dna in bacteria |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN115404154A (en) |
| WO (1) | WO2022237338A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116855359A (en) * | 2023-07-11 | 2023-10-10 | 江苏谱新生物医药有限公司 | System and method for alkaline lysis of plasmid |
| CN117431149A (en) * | 2023-12-22 | 2024-01-23 | 北京艺妙神州医药科技有限公司 | Method for washing thalli |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1523033A (en) * | 2003-07-10 | 2004-08-25 | 余伟明 | Plasmid DNA purifying method by phase separation method |
| CN1958800A (en) * | 2006-11-23 | 2007-05-09 | 广东省农业科学院兽医研究所 | Method for extracting plasmid DNA, and extraction device |
| CN101006170A (en) * | 2004-04-19 | 2007-07-25 | 森特利昂公司 | Method for purifying plasmid DNA |
| CN102242115A (en) * | 2011-07-21 | 2011-11-16 | 河南惠尔纳米科技有限公司 | Kit for extracting bacterial plasmid DNA (deoxyribonucleic acid) by magnetic beads, and extraction method thereof |
| CN111979109A (en) * | 2020-09-01 | 2020-11-24 | 深圳普瑞金生物药业有限公司 | Plasmid vector continuous cracking device |
-
2021
- 2021-05-10 CN CN202110506985.5A patent/CN115404154A/en active Pending
-
2022
- 2022-03-24 WO PCT/CN2022/082709 patent/WO2022237338A1/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1523033A (en) * | 2003-07-10 | 2004-08-25 | 余伟明 | Plasmid DNA purifying method by phase separation method |
| CN101006170A (en) * | 2004-04-19 | 2007-07-25 | 森特利昂公司 | Method for purifying plasmid DNA |
| CN1958800A (en) * | 2006-11-23 | 2007-05-09 | 广东省农业科学院兽医研究所 | Method for extracting plasmid DNA, and extraction device |
| CN102242115A (en) * | 2011-07-21 | 2011-11-16 | 河南惠尔纳米科技有限公司 | Kit for extracting bacterial plasmid DNA (deoxyribonucleic acid) by magnetic beads, and extraction method thereof |
| CN111979109A (en) * | 2020-09-01 | 2020-11-24 | 深圳普瑞金生物药业有限公司 | Plasmid vector continuous cracking device |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116855359A (en) * | 2023-07-11 | 2023-10-10 | 江苏谱新生物医药有限公司 | System and method for alkaline lysis of plasmid |
| CN117431149A (en) * | 2023-12-22 | 2024-01-23 | 北京艺妙神州医药科技有限公司 | Method for washing thalli |
| CN117431149B (en) * | 2023-12-22 | 2024-03-08 | 北京艺妙神州医药科技有限公司 | Method for washing thalli |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115404154A (en) | 2022-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022237338A1 (en) | Device for extracting plasmid dna in bacteria | |
| DK2364769T3 (en) | Apparatus and methods for biomaterialeproduktion | |
| US20200017819A1 (en) | Compositions comprising high concentration of biologically active molecules and processes for preparing the same | |
| US7771945B2 (en) | Apparatus and method for preparative scale purification of nucleic acids | |
| Hoare et al. | Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic | |
| US20220339554A1 (en) | Continuous Sample Purification Systems and Methods | |
| CA2212446C (en) | Method for lysing cells | |
| WO2022237337A1 (en) | Method for extracting plasmid dna in bacteria | |
| CN1229172C (en) | Vessel for mixing cell lysate | |
| CN1948481A (en) | Method of continuous large quantity extracting plasmid | |
| EP3594338A1 (en) | Method and apparatus for the purification of extra-chromosomal nucleic acid sequences | |
| CN112940915A (en) | Plasmid extraction device and method | |
| CN216727230U (en) | Separation and purification equipment | |
| Murphy et al. | Large-scale, nonchromatographic purification of plasmid DNA | |
| CN1321181C (en) | Method for extracting basically pure plasmid by improved alkaline cracking method and multilayer chromatographic device | |
| EP1398072A1 (en) | A vessel for mixing a cell lysate | |
| KR20240027805A (en) | Automated plasmid extraction | |
| WO2023132963A1 (en) | Purification of macromolecules | |
| CN117050874A (en) | RNA in-vitro transcription biological reaction device | |
| CN112424337A (en) | A lysis coil device for separating and purifying polynucleotides and uses thereof | |
| CA2710777A1 (en) | Method for lysing cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22806308 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |